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Nucleotide pyrophosphatase/phosphodiesterase 6 (NPP6) is a membrane 
anchored ectoenyzme expressed in the brain and kidney.  It is the sixth member 
of the NPP family.  Currently, the family consists of seven members, NPP1-
NPP7.  Each member was numbered according to the order in which it was 
associated with the NPP family.  NPP isoforms hydrolyze a wide range of 
substrates such as lipids, nucleotides, and their derivatives.  NPP1, NPP2 and 
NPP3 hydrolyze nucleotides (and derivatives).  NPP6 and NPP7 along with 
NPP2 hydrolyze phosphodiester bonds in lipids (and derivatives).  Thus far, 
NPP4 and NPP5 have yet to be characterized in terms of substrate specificity.  
Many of the hydrolytic pathways of NPP enzymes lead to the formation of 
bioactive lipids that affect numerous pathological, as well as physiological 
processes.  This, combined with their extracellular action, makes them suitable 
targets for therapeutic intervention.        
NPP6 is expressed predominately in the kidneys where it plays a role in 
choline reabsorption.  Choline is needed to maintain healthy kidneys; however 
over time choline degrades and the body does not replenish it.  Therefore, 




Here, we focused on testing and identifying additional substrates of NPP6.  
Our results show that NPP6 is not a very promiscuous enzyme.  Overall, NPP6 
preferred smaller substrates as opposed to larger substrates.  Like another 
member of the NPP superfamily, NPP7, NPP6 has lysophospholipase C activity.  
We identified lysophosphatidic acid 16:0 (LPC 16:0) and para-nitrophenyl 
phosphocholine (pNPPC) as highly potent substrates for NPP6.    
Next, we focused on characterizing the structure and function of NPP6.  
Given that very little is known about the structure and function of NPP6, insight 
into this area may assist in the design of chemical probes to address NPP6 
physiological roles.  All NPP family members hydrolyze a wide range of 
substrates but exhibit unique substrate specificity profiles.  Currently, little is 
known about what defines the varying substrate specificity among the enzymes.   
To explore substrate specifying determinants for NPP6, we used computational 
modeling as a rational tool to guide selection of substrate recognition residues to 
experimentally mutate.  We selected known substrates such as LPC 16:0 and 
pNPPC and docked each into the NPP6 homology model.  The experimental 
results validated the model suggesting the presence of a common binding pocket 
for the different substrates of NPP6.  Furthermore, the experimental studies 
provide validation of our model for hydrogen bond interactions between the 
substrate and specific amino acid residues either during substrate recognition or 
during the catalytic process.       
The catalytic domain of the NPP superfamily has been related to those of 
other sulfo- and phospho- coordinating metalloenzymes which include the 
vi 
 
alkaline phosphatase superfamily.  Both the alkaline phosphatases and NPPs 
possess two divalent metal cations within their binding pocket and are inactivated 
by removal of the endogenous divalent metals.  Until now, the role of the 
endogenous divalent metals has been unknown.  Here, we show that the 
secondary structure is not affected by the presence or absence of the 
endogenous divalent metals; although the catalytic activity is eliminated upon 
overnight incubation with the metal chelator, EDTA.  Attempts to restore the 
catalytic activity of NPP6 were made.  Results showed that Ca2+ and Zn2+ 
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Abbreviations for the 20 common amino acid residues and 4 bases in DNA 
 
Residue/Base 1-letter Abbreviation 
3-letter 
Abbreviation 
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Glutamine Q Gln 
Glutamic Acid  E Glu 
Glycine G Gly 
Guanine G N/A 
Histidine H His 
Isoleucine I Ile 
Leucine L Leu 
Lysine K Lys 
Methionine M Met 
Phenylalanine F Phe 
Proline P Pro 
Serine S Ser 
Threonine T Thr 
Thymine T N/A 
Tryptophan W Trp 
Tyrosine Y Tyr 















Alkaline phosphatase AP 
Adenosine monophosphate AMP 
Bis(p-nitrophenyl) phosphate bis-pNPP 
Circular dichroism CD 
Deoxyribonucleic acid DNA 
Ethylenediaminetetraacetic acid EDTA 
Ethidium bromide EtBr 
Fast protein liquid chromatography  FPLC 
Glycerolphosphorylcholine GPC 
Human embryonic kidney 293 HEK293 
Isopropyl β-D-1-thiogalactopyranoside IPTG 
Lysophosphatidic acid LPA 
Lysophosphatidyl choline LPC 
Lysophospholipase C LPLC 
Lysophospholipase D LPLD 
Molecular dynamics MD 
Molecular Operating Environment MOE 
Monoacylglycerol MAG 
Nucleotide pyrophosphatase/phosphodiesterase NPP 
Open reading frame ORF 
Para-nitrophenyl phenyl phosphate pNPPP 
Para-nitrophenyl phosphocholine pNPPC 
Para-nitrophenyl thymidine 5'-monophosphate pNP-TMP 
Phosphoryl n-oleoyl ethanolamine  PC-OEA 
Phophocholine PC 
Polymerase chain reaction PCR 
Polyvinylidene difluoride  PVDF 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis SDS-PAGE 
Sphingosylphosphorylcholine SPC 
Spodoptera frugiperda 9 Sf9 
Wild type WT 






1.1. PROTEIN SYSTEMS 
1.1.1. NUCLEOTIDE PYROPHOSPHATASE/ 
PHOSPHODIESTERASE (NPP)  
The nucleotide pyrophosphatase/phosphodiesterase (NPP) family 
consists of seven structurally-related proteins (Figures 1 & 2) [1-3].  Each is 
numbered according to the order in which it was associated with the NPP family 
[3-5].  All NPPs share a homologous catalytic domain and catalytic site residue, 
along with two divalent metal cations of unknown identity [7].  The predominant 
catalytic residue found among family members is threonine, with the exception, 
serine, occurring in NPP6 [7].  The full-length sequence consists of 
approximately 400 or 800 amino acids with 24-60% residue identity among the 
different human isoforms [8].  A phylogenetic tree shows that NPP4-NPP7 form a 
subfamily within the NPP superfamily (Figure 1).  Further research has 























































Figure 1. A phylogenetic tree showing the relationship between 
members of the NPP family 
2 
 
Most NPPs are single-spanning transmembrane domain proteins.  NPP4-
NPP7 contain an extracellular N-terminal signal peptide and a C-terminal 
transmembrane domain which places their N–termini on the extracellular side of 
the membrane, thereby exhibiting type-I orientation [4, 8-10].  NPP1 and NPP3 
have a transmembrane domain at their N-termini exposing the C–terminal end of 
the protein to the extracellular space, therefore exhibiting type-II orientation [11].  
NPP2, on the other hand, is not a transmembrane protein, but is synthesized as 
a pre-pro-enzyme [1-2, 12-13].  Removal of the N-terminal signal peptide 
followed by cleavage with a furin-type protease results in secretion of NPP2 into 
the extracellular matrix [14].  It is because their catalytic domains are 
extracellular, whether anchored at the membrane or not, that members of the 
NPP superfamily of proteins are considered ecto-enzymes.  As the domains and 




Overall, NPP isoforms catalyze the hydrolysis of a variety of nucleotides 
and lysophospholipids.  NPP1 and NPP3 preferentially hydrolyze nucleotides and 
their derivatives [15].  Substrates for NPP4 and NPP5 are currently unknown 
[16].  NPP6 and NPP7, along with NPP2, hydrolyze phosphodiester bonds in 
lysophospholipids [3-4]. However, they possess different regioselectivities.  
NPP2 hydrolyzes lysophosphatidyl choline (LPC) to generate lysophosphatidic 
acid (LPA) and choline, termed lysophospholipase D (LPLD) activity [15, 17]; 
whereas NPP6 [4] and NPP7 [3] have lysophospholipase C (LPLC) activity, 






























Adapted from Cristiana Stefan, Silvia Jansen and Mathieu Bollen “NPP-type ectophosphodiesterases: unity in diversity”
 












While their substrates vary widely, alkaline phosphatases (APs) and NPPs 
are proposed to share similar catalytic mechanisms, as metal-coordinating amino 
acids and catalytic residue are conserved in both families of enzymes [8].  This 
catalytic mechanism is generally described as a two step process [8].  In the first 
step, the metal-activated oxygen of the catalytic residue attacks the electrophilic 
phosphate of an incoming substrate, displacing a leaving group to form a diester 
linkage with the phosphate group.  Subsequently, a water molecule is activated 
by the second metal, and attacks the intermediate, releasing the product. The R 
group in the endogenous substrate for NPP6, LPC, would be monoacylglycerol 
(Figure 4).  Detailed mechanistic studies have not been performed to provide 
support for the concerted steps described, so it is possible that either or both 




















































Although the detailed catalytic mechanism has yet to be determined, 
members of the NPP superfamily of proteins are of great interest to study due to 
their involvement in several biological processes, such as cancer, ectopic 
mineralization and insulin resistance [16].  NPP-mediated effects include bone 
mineralization and soft tissue calcification for NPP1 [1-2]; cell proliferation, 
migration and survival for NPP2 [15]; allergies for NPP3 [10, 18]; choline 
reabsorption by the kidneys for NPP6 [4]; and cholesterol absorption and 
























































































All NPPs, except for NPP2, are found at the cell surface as membrane 
anchored enzymes; but like NPP2, they can also be found as secreted or 
shredded proteins [6].  Given that the NPP family members function 
extracellularly, compounds that act on these enzymes, such as inhibitors and 
activators (effectors), do not require cell permeation.  Since good effectors 
depend on the accessibility of the enzyme, the NPPs are attractive as therapeutic 




 NPP6 is the sixth member of the NPP superfamily. Sakagami and 
colleagues first cloned the cDNA for NPP6 [4].  The cDNA contained a 1323 
base pair open reading frame (ORF).  The ORF encoded 440 amino acids with a 
predicted molecular mass of 50,240 Da.  As noted previously, the amino acid 
sequence of NPP6 is more similar to those of NPP4, NPP5, and NPP7 than 
those of NPP1-NPP3.   
NPP6, a membrane bound protein, was previously expressed in HeLa 
cells by Sakagami and colleagues [4].  Western blot analysis detected a 50 kDa 
protein, with most of the protein localized in the cell pellet.  Only a small amount 
of protein was detected in cell culture medium [4].  To determine cellular 
localization of NPP6, Sakagami and colleagues performed fluorescence imaging 
to demonstrate that the protein was localized to the plasma membrane [4].  They 
speculated that a stretch of hydrophobic amino acid residues located at the 
carboxyl terminus of NPP6 anchored the protein to the membrane.  To determine 
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if this hydrophobic stretch of amino acids comprised the transmembrane region, 
NPP6 was truncated (deleting amino acid residues 422-440).  When transiently 
transfected into HeLa cells most of the truncated NPP6 was recovered in the cell 
culture medium.  Thus, the hydrophobic stretch of amino acids is responsible for 
anchoring NPP6 to the membrane, where NPP6 acts as a choline-specific 
glycerophosphodiesterase to hydrolyze phospholipids.   
As mentioned before, NPP6 hydrolyzes LPC to produce MAG and PC.  
Currently, NPP6 is known to recognize several substrates, both natural and 
synthetic (Figure 5).  The natural substrates include LPCs (12:0, 14:0, 16:0, 18:0, 
18:1, 18:2, 20:0, 20:4) [4], glycerophosphorylcholine (GPC) [4], 
phosphorylcholine n-oleoyl ethanolamine (PC-OEA) [19], and 
sphingosylphosphorylcholine (SPC) [4].  Para-nitrophenyl phenyl phosphate 
(pNPPP), para-nitrophenyl thymidine 5’-monophosphate (pNP-TMP), para- 
nitrophenyl phosphocholine (pNPPC), and bis(p-nitrophenyl) phosphate (bis-
pNPP) are synthetic substrates known to be hydrolyzed by NPP6 [4]. 
 1.2. KNOWLEDGE GAPS 
Currently, little is known regarding the structure and function of NPP6.  
NPP6 is presumed to play a role in choline reabsorption in the kidneys.   In the 
kidneys, NPP6 is expressed within the proximal tubules and thin descending 
limbs of the loop of Henle [4].  Within the tubules, NPP6 is suspected to have 
specific roles.  Characterizing the structure and function of this enzyme is 




Studying substrate interactions using site-directed mutagenesis will aid in 
our understanding of several key factors such as which residues are important 
for recognizing substrates and provide insight into new substrate identification 
(Figure 6).  Therefore, residues predicted to interact with known substrates by 
computational modeling were selected for mutation to validate the insight into the 
NPP6 binding pocket provided by the model.  
The role of the endogenous metals within the binding pocket is another 








functional role?  We answered this question as described in Chapter 2 by testing 
the catalytic activity and structural integrity after metal removal and restoration.  
Function and structure were investigated using activity assays and circular 
dichroism (CD) experiments, respectively. 
Little is known about NPP6 regarding substrate-residue interactions. 
Determining substrates which NPP6 can hydrolyze will aid in our understanding 
of the catalytic core.  An array of substrates previously found to be hydrolyzed by 
the other members of the NPP family were tested against NPP6 as described in 
Chapter 2.  This allowed us to answer questions such as what substrates are 
specific to NPP6 and what substrates are hydrolyzed by both NPP6 and other 
members of the superfamily?  These key factors aided in the overall validation of 
the NPP6 model.    
Finally, the manner by which substrates and NPP6 residues interact is 
unknown.  The site-directed mutagenesis studies described in Chapter 3 allowed 
us to study the source of enzyme affinity for substrates.  This aided in our 
understanding of how the substrate binds and is hydrolyzed within the substrate-
binding pocket. 
Currently, it is suggested that NPP6 plays a role in choline reabsorption.  
In the future, if NPP6 is found to be the sole source of choline reabsorption in the 
kidneys, validation of the NPP6 binding pocket may serve as a template 
regarding how to study this dilemma and as a target for therapies. Our NPP6 
model could aid in the design and discovery of novel NPP6 activators or 





































1.3. Enzyme Kinetics  
To understand the mechanism of an enzyme-catalyzed reaction the rate of 
the reaction and how it changes in response to changes in experimental 
parameters need to be studied.  This type of study is called enzyme kinetics and 





Figure 6.  Project map of the functional and structural characterization of 
NPP6.  Two components, experimental and computational, were integrated to 
produce a validated NPP6 model.  Experimentally, DNA was generated, protein 
was expressed and purified, and function was verified.  Computationally, a 
homology model was generated and residue-substrate interactions were 
visualized.   
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The free enzyme (E) combines reversibly with substrate (S) to form ES.  
This step (left side of Equation 1) is assumed to happen at a relatively fast rate 
compared to when the ES complex breaks down to yield free E and product (P).   
We ignore the reverse reaction, conversion of P to S, because the concentration 
of P is negligible in the early stages of the reaction and the conversion to product 
is assumed to be irreversible.  When the substrate concentration becomes high 
enough to entirely convert the enzyme to the ES form (right side of Equation 1) 
the overall reaction rate (Vo) becomes insensitive to further increases in substrate 
concentration, and the maximal rate (Vmax) is observed (Equation 2).   
 
 
This equation is applicable when two simplifying assumptions can be made.  
First, the assumption of equilibrium [20] which states that k-1 >> k2 so that the first 
step of the reaction achieves equilibrium.  Second, the assumption of steady-
state [20] which states that [ES] remains approximately constant until the 
substrate is nearly exhausted.  A reaction rate, Vo, is the number of reactions per 
second catalyzed per mole of enzyme.  With increasing substrate concentration 
[S], the reaction rate increases approaching the maximum rate, Vmax.  Therefore, 
E + P
k2
E + S ES
k1
k-1   (Equation 1) 
Vo   =    Vmax [S]
Km + [S]       (Equation 2) 
12 
 
there is no single substrate concentration at which the enzyme will be saturated 
with substrate.  To characterize an enzyme, the single substrate concentration at 
which the reaction rate reaches half of its maximum value (Vmax/2) can be used.  
This concentration can be shown to be equal to the Michaelis constant, also 
known as Km.  An enzyme that has a small Km value achieves half-maximal 
catalytic efficiency at low substrate concentrations.  In general, Km changes as a 
function of temperature and pH.    Since Kd is the dissociation constant of the 
Michaelis complex, as Kd decreases, the enzyme’s affinity for substrate 
increases.  Km is therefore also a measure of the affinity of the enzyme for its 
substrate providing k2/k1 is small compared with Kd, that is, k2 < k-1.  But, if k2 is 
larger than k-1, then Km = k2/k1, and Km does not directly reflect the affinity for a 
substrate.  Km can also reflect the affinity when the total enzyme concentration 
(ET) does not change over time.  kcat, also called turnover number or catalytic 
constant, describes the limiting rate of any enzyme-catalyzed reaction at 
saturation.  kcat refers (Equation 3) to the number of substrate molecules 
converted to product in a given time by a single enzyme molecule when the E is 
saturated with S.  Vmax = k2 [Et] in the Michaelis-Menten model indicates that kcat 
= k2.   
Km and kcat allow us to evaluate the kinetic efficiency of enzymes.  
However, we cannot use Km or kcat alone because two enzymes that catalyze 
different reactions may have the same kcat, yet the rates of the uncatalyzed 
reactions may be different.  Therefore, the best way to compare the enzymes is 
kcat = Vmax / [Et]      (Equation 3) 
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to use the ratio kcat/Km for the two reactions.  kcat/Km, defined as the specificity 
constant or the catalytic efficiency, is the rate constant for the conversion of E + 
S to E + P when S is less than Km.  The quantity kcat/Km is a measure of an 
enzyme’s catalytic efficiency. 
Here, we performed kinetic analysis studies on WT and mutant protein.  
We picked one enzyme concentration with varying concentrations of substrate to 
react with the enzyme over a period of time.  Linear segments in the plots of 
product formation as a function of time were obtained and used for initial 
velocities matched with corresponding substrate concentrations.  Both substrate 
concentrations and velocities were  plotted using Kaleidagraph [Synergy 
Software, 4th ed, PA] [21], a graphing and data analysis tool, where  a 












    
Velocity = Vmax * 1/Km [S] * (1 + 1/Km * [S])  (Equation 4) 
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2.  FUNCTIONAL AND STRUCTURAL CHARACTERIZATION 
2.1. NPP6 EXPRESSION AND PURIFICATION  
 NPP6 is a membrane-bound protein, anchored via a C-terminal 
transmembrane domain.  Elimination of the C-terminus releases the truncated 
protein (NPP6ex) into the extracellular matrix, producing a soluble functional  
protein [4].  Three expression systems were used to express soluble NPP6.  
These included bacterial, mammalian and insect expression systems. 
2.1.1. BACTERIAL EXPRESSION SYSTEM 
 
The bacterial expression system is the one most often used because of its 
simplicity and low cost.  This expression system produces protein in a short time 
(approximately 1-24 hours), as bacteria grow and multiply rapidly with a high 
yield.  For this reason, the bacterial expression system was the first choice to 
express the NPP6ex protein. 
2.1.1.1. PLASMID DESIGN  
NPP6ex was acquired from Dr. Junken Aoki (University of Tokyo).  The 
NPP6ex gene was originally cloned into pCAGGS-MCS [4].  NPP6ex was 
cleaved from the pCAGGS-MCS plasmid using the EcoRI and XhoI nucleases, 
purified by gel electrophoresis and extraction, and ligated into a vector plasmid 
that had been linearized by restriction endonuclease cleavage by EcoRI and 
XhoI (Figure 7).  An appropriate vector plasmid was chosen based on a specific 
purification tag and cloning/expression region.  The pET24b(+) plasmid vector 
(5309bps), carrying a C-terminal His-tag, with a kanamycin resistance gene, was 
used in this case. By constructing a plasmid with an antibiotic resistance gene, 
when bacteria replicate in the presence of the antibiotic, only bacteria bearing the 
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plasmid survive.  NPP6ex was inserted into the cloning/expression site of 
pET24b(+) in the correct orientation.  The C-terminal His-tag was composed of a 
segment of six histidines that were located at the end of the plasmid’s open 
reading frame (ORF).  Sakagami and colleagues modified the NPP6ex-
containing plasmid to contain a stop codon at the end of the ORF, preventing 
DNA polymerase from reading the His-tag [4].  This stop codon (TAG changed to 
TTG) was altered by QuikChange Site-Directed Mutagenesis discussed in 
section 2.1.4.1. [Stratagene] (Figure 22), allowing expression of the His-tag at the 







Figure 7:  pET24b(+) plasmid with endonuclease cleavage sites Xho I and 
EcoR I in the multiple cloning site (MCS).  Locations of His-Tag coding 









Table 1:  Oligonucleotides for pET24b(+) insert sequencing 
Primers Sense oligo/primer Anti-sense oligo/primer 
 Primer A designed to 
verify insertion of 






 Primer B designed to 
verify insertion of 






T7 Promoter to verify 







T7 Terminator to verify 







Alter stop codon -primer 
designed to convert stop 








Bold segments denote the mutagenic site.  The gray segments are restriction 
endonuclease cleavage sites.  
17 
 
2.1.1.2. DNA VERIFICATION 
NovaBlue competent cells were transformed by the NPP6ex plasmid 
according to section 2.1.4.2.   Plasmid DNA was purified using the QIAspin 
Qiagen Miniprep kit and analyzed using agarose gel electrophoresis as 
described in section 2.1.4.3.  A band of expected size, ~5 kilobase pairs (kbp) 
was visualized by ultraviolet (UV) light (Figure 8).  Upon confirmation of size, the 
newly purified plasmid DNA containing NPP6ex was sent to the University of 
Tennessee Health Molecular Research Center (UTHMRC) for sequencing using 
the primers in Table 1.  All further DNA sequencing experiments were performed 
by UTHMRC. 
2.1.1.3. PROTEIN EXPRESSION AND PURIFICATION 
After DNA sequence verification, Rosetta (DE3) [Novagen] competent 
cells were transformed with NPP6ex as explained in section 2.1.4.2., using 
kanamycin as the antibiotic (30mg/L).  The fusion protein was identified using 
SDS-PAGE as described in section 2.1.4.3.2. and compared to the Kaleidoscope 
Precision Plus Protein Standard (BioRad).   
In addition, NPP6ex was characterized by western blot according to 
section 2.1.4.6., and visualized using X-ray film.  The western blot verified the 





Very little protein was discovered in the soluble fraction compared to the 
whole cell and cell pellet for both the SDS-PAGE and western blot (Figure 9).  
Given that little protein was obtained in the soluble fraction during all bacterial 
expression, experiments in the mammalian and insect expression systems were 
explored.   
Nickel column purification of NPP6ex was performed.  Cleared lysate from 
bacterial cells was loaded on a nickel column and separation was performed 
using FPLC according to sections 2.1.4.4.1. and 2.1.4.4.2, respectively.  The 
chromatogram (Figure 10, panel A) showed elution of a protein around fractions 




Figure 8:  DNA of pET24b(+) (vector) containing NPP6ex (insert) .  1, HiLow 
DNA ladder [Fermentas].  2, pET24b(+):NPP6ex DNA was incubated for 1 hour 
at 37ºC with both restriction endonucleases, EcoR I and XhoI.  DNA (1ng) was 
separated on 2% agarose gel and stained with ethidium bromide for.  3, 





2.1.4.3.2.).  Partially purified protein was found in fractions 15-20 at 50 kDa 
(Figure 10, panel B). 
SOLUBILITY STUDIES 
In an attempt to extract more soluble protein, several solubility studies 
were performed.  In general, protein is easier to purify in functional form from 
soluble cellular fractions than from insoluble fractions.  The majority of NPP6ex 
was found in the insoluble cellular fractions.  To promote NPP6ex localization in 
the soluble fractions several experiments were designed including OD variations, 
IPTG concentrations, and bacterial growth temperatures.   
The first experiment was designed to show if inducing the bacterial cells 
with 1mM IPTG at varying OD helped protein solubility.  Bacteria were grown 
according to section 2.1.4.2. with the exception that the cells were collected 
when the cell density, as determined by OD600 reached 0.3, 0.6, or 0.9 before 
induction.  Whole cells and cell lysates were collected, normalized, and analyzed 
by SDS-PAGE (2.1.4.3.2.) to determine the proportion of protein in the soluble 
fraction.  Results were similar to those in Figure 9. 
In another experiment, concentrations of IPTG were varied.  Bacterial 
cultures were grown according to section 2.1.4.2. with varying amounts of IPTG 
(1mM, 0.1mM, and 0.01mM) added to induce NPP6ex expression.  Cells were 
normalized and analyzed by SDS-PAGE (section 2.1.4.3.2.).  Studies showed 
that increasing IPTG concentration modestly increases protein solubility (Figure 
11).   
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In a different experiment, a cell expression time course was examined for 
0, 2, 4 hours and overnight.  Bacteria were grown according to section 2.1.4.2.  
No improvement in protein proportion in the soluble fraction was obtained as a 
function of collection time (data not shown).    
Next, a temperature-dependence study was performed.  Bacteria were 
grown and collected according to section 2.1.4.2. at both 16ºC and 37ºC. No 
improvement in soluble protein proportion was obtained at the lower growth 








Figure 9:  Expression of NPP6ex protein. Rosetta cells were transformed 
with NPP6ex and grown in 100ml cultures with 1mM IPTG.  The cells were 
grown to an OD600 = 0.6 before induction with IPTG and harvested by 
centrifugation after 4 hours. A, SDS-PAGE.    B, Western blot.  Lanes in 













Figure 10: Purification of NPP6ex.  Bacteria were induced at OD600=0.6 with 
1mM IPTG for 4 hours.  Cell lysate was loaded on a 1mL HiTrap column for 
FPLC purification and 1mL fractions were collected and analyzed by SDS-
PAGE.  A, Chromatogram displaying signal at 405 nm as a function of time.  
B, SDS-PAGE analysis of fractions.  1, Kaleidascope precision plus protein 
ladder. 2-7, fractions 20-15.  8-9, column after lysate loading.  10-11, flow 
through from column loading.  12, Kaleidascope precision plus protein ladder.  
13, loading sample obtained before the protein was added to the column.  14, 




















Figure 11:  Expression of NPP6 protein varying IPTG concentrations.  
Bacteria were grown and induced with varying concentrations (0.01, 0.1, 
and 1mM) of IPTG.  1, Kaleidascope precision plus protein ladder.  2, 
empty lane.  3 and 4, W.C. and C. L. collected from a 100ml culture 
induced with 1mM final concentration of IPTG.  5 and 6, W.C. and C. L. 
collected from a 100ml culture induced with 0.1mM final concentration of 
IPTG.  7 and 8, W.C. and C. L. collected from a 100ml culture induced with 






Figure 12:  Expression of NPP6 protein varying cell collection time.  
Bacteria were grown and induced with 1mM IPTG when the cell OD600 = 
0.6.  Whole cells and cleared lysates were collected at 0, 2 or 4 hours after.  
1, Kaleidascope precision plus protein ladder. 2 and 3, 0 hours samples.  4 




The celLytic B Lysis kit (Invitrogen) and sonication were used in an 
attempt to determine which better separates soluble from insoluble cell fractions. 
Samples from both experiments were analyzed by SDS-PAGE as explained in 
section 2.1.4.3.2.  Neither of the techniques used produced a significant amount 
of soluble protein to further perform protein characteristic studies.  Obtaining 
enough soluble protein from the inclusion bodies was not possible through the 
bacterial expression system; therefore a Cell-Free E. coli Expression System 
was investigated [22]. 
The Cell-Free E. coli Expression System kit [Invitrogen] is a procedure to 
obtain protein without whole cells [23-26].  Samples were run on SDS-PAGE as 
 
 
Figure13:  Expression of NPP6 protein varying temperatures.  Bacteria 
were grown to an OD600 = 0.6 and induced with 1mM IPTG at two different 
temperatures, 16ºC and 37ºC.  Bacteria were collected after 4 hours of 
incubation with IPTG induction.  1, the Kaleidascope precision plus protein 
ladder was added as a standard. 2 and 3, W.C. and C.L. were collected 
from a 100ml culture induced with 1mM IPTG.  Protein was not expressed.   
4 and 5, W.C. and C.L. were grown at 37ºC and collected.  10% protein 
was found in the soluble fraction.  6 and 7, W.C. and C.L. were grown at 





described in section 2.1.4.3.2.  The Cell-Free E. coli Expression System kit did 
not produce any further soluble protein (Data not shown). 
 2.1.2. MAMMALIAN EXPRESSION SYSTEM 
 The mammalian expression system is designed to produce high-level 
stable and transient expression of protein in mammalian hosts.  The plasmids 
picked to express NPP6ex were expression vectors pcDNA 3.1(+) and pcDNA 
3.1(-).  These are 5.4 kb vectors in forward (+) and reverse (-) orientations, 
respectively, to facilitate cloning.  Unfortunately, low protein yields are common 
to mammalian expression systems due to slow cell growth.  Mammalian cells 
also require careful handling. 
  2.1.2.1. PLASMID DESIGN 
The NPP6ex modified plasmid, constructed to work with the bacterial 
expression system, was incompatible with the mammalian expression system.  
Here, we chose the pcDNA3.1 (+) plasmid because it had the correct orientation 
for insertion of the NPP6ex gene cassette and was used to make the 
recombinant plasmid. NPP6ex was subcloned into pcDNA3.1 (+) at 
endonuclease sites EcoRI and XhoI (Figure 14).   
A Flag purification tag was selected concurrently with the change in 
expression systems due to the success observed in a different protein 
purification project by another group member, Dr. Truc-Chi Pham.  A C-terminal 
FLAG-tag and stop codon was added by the Quick Change Site-Directed 
Mutagenesis kit described in section 2.1.4.1.  The FLAG-tag (DYKDDDDK) was 
added after amino acid position 419 to make purification easier.  The addition of 
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the stop codon was designed to terminate the sequence after the insertion of a 
FLAG-tag.  Primers for these modifications are shown in Table 8.   
 
 
2.1.2.2. DNA VERIFICATION 
The pET24b(+) plasmid-containing NPP6ex was transformed into 
NovaBlue competent cells and analyzed by gel electrophoresis according to 
sections 2.1.4.2 and 2.1.4.3.1., respectively.  The correct DNA size (~5kbp) was 
obtained and sequenced.  Figure 15 shows DNA fragments of WT and mutant 
genes generated to validate the homology model (chapter 2).  DNA size 
appeared uniform for all mutants around 5kb.  Mutant selections are explained in 






Figure 14:  pcDNA3.1(+) plasmid with restriction sites Xho I and EcoR I 
in the multiple cloning site (MCS).  Locations of BGH coding sequence, 






 2.1.2.2.1. PROTEIN EXPRESSION AND PURIFICATION 
Time trials of 24 and 48 hours were analyzed to optimize growth 
conditions (section 2.1.4.2).  The optimal protein level in media occurred 48 
hours after transfection.  Once the media was collected, it was centrifuged at 
1,000xg for 5 minutes and 0.2% FBS was added to the sample and stored in the 
4ºC refrigerator.  Samples were concentrated according to section 2.1.4.5.  Due 
to the small amount of protein generated from the mammalian expression 















Table 2:  Oligonucleotides used to modify and sequence the mammalian 
expression vector.   
 
Primers Sense oligo/primer Anti-sense oligo/primer 
Add flag-tag primer 
designed in insert into 













Add stop codon -primer 








BGH Primer designed to 






T7 Promoter designed to 
verify insertion of 











Table 3: Mutation primers for pcDNA3.1(+)   
 
Mutation 
















































































































































2.1.2.2.2. PROTEIN CHARACTERIZATION BY WESTERN 
BLOT 
Protein concentrations were normalized after performing numerous 
western blots.  Varying concentrations of protein (20x, 10x, and 5x) were added 
to the SDS-PAGE (described in section 2.1.4.3.2.) to compare the band 
intensities of each mutant.  Bands were transferred to a PVDF membrane (Bio-
Rad) as described in section 2.1.4.6.  Normalized protein amounts were 
prepared based on these intensities and western blot analysis repeated to 
confirm matching protein levels in each mutant (Figure 16).  The protein standard 
used was carboxy-terminal FLAG-BAP fusion protein which was run at 
0.49mg/ul.  Once uniform band intensity was visualized for each mutant, the 
bands were normalized to the standard using the computer software TotalLab.  
The rubber band method was used for background subtraction.  Peak volumes 
were used to obtain normalizing protein values.  Peak volume ratios were used to 













Figure 15: DNA 2% agarose gel electrophoresis.  All mutant plasmids 
were transformed into NovaBlue competent cells, grown in bacteria, and 






















































































Figure 16:  Western blot image of normalized protein based on the 
volume ratios provided.   
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2.1.3. INSECT EXPRESSION SYSTEM 
 The insect expression system, also known as the Bac-to-Bac Baculovirus 
Expression System, provides a rapid and efficient method to generate 
recombinant baculoviruses [27-28].  This method produces high yields of protein 
at a relatively fast turnaround.  However, compared to the bacterial and 
mammalian expression systems, the insect expression system is the most 
susceptible to contamination. 
  2.1.3.1. PLASMID DESIGN 
The modified-NPP6ex plasmid, constructed to work with the bacterial 
expression system was also incompatible with the insect expression system.  
Therefore, the pFastBac™1 plasmid was created using the same procedures 





























Figure 17: pFastBac™1 plasmid shown with restriction sites EcoR I and 





The insect expression system utilizes the pFastBac™1 donor plasmid that 
allows generation of an expression construct with NPP6ex.  The NPP6ex gene 
was subcloned into pFastBac™1 which then was transformed into MAX 
Efficiency DH10Bac cells.  E. coli colonies with the recombinant bacmid were 
picked, streaked, and restreaked to verify E. coli colonies containing recombinant 
bacmid.  The colonies were picked and grown in 10ml cultures overnight to 
isolate the recombinant bacmid DNA.   
  2.1.3.2. DNA VERIFICATION  
 
.  The bacmid is approximately 135kb in size, too large to sequence; 
therefore PCR analysis was used to verify the presence of the gene. Bands 









Figure 18:  DNA 2% agarose gel of mutants made for expression in Sf9 cells.    
2% agarose gel analysis of recovered bacmid DNA.  Mutants and WT were 





2.1.3.3. PROTEIN EXPRESSION AND PURIFICATION 
After amplification of the bacmid, 8ug of DNA was transiently transfected 
into the fall armyworm Spodoptera frugiperda (Sf9) cell line using the Cellfectin 
Transfection Reagent (section 2.1.4.2.).  Similarly to polyfect in the mammalian 
cells, the Cellfectin Reagent assembles DNA into compact structures, facilitating 
the entry of DNA into the cell. 
A time course trial comparing 48, 72, and 96 hours was performed to 
optimize growth conditions (Figure 19).  The optimal condition determined to 
collect NPP6ex protein was 48 hours post-transfection.  Therefore, forty-eight 
hours after infection, the cells were collected and centrifuged at 1,000xg for 5 
minutes.  0.2% FBS was added to the sample and stored at 4ºC.  The protein 















Figure 19:  Western blot of protein expressed from Sf9 cells.  A time-
course (24, 48, and 96 hours) was performed to determine the optimal time to 
collect protein.  Samples of pellet and cleared lysates were taken.  1, pellet at 
96 hours.  2, cleared lysate at 96 hours.  3, pellet at 48 hours. 4, cleared 
lysate at 48 hours.  5, plellet after 24 hours. 6, cleared lysate after 24 hours.  





2.1.3.4. PROTEIN CHARACTERIZATION BY WESTERN 
BLOT  
Purified NPP6ex was run on a western blot according to section 2.1.4.6.  
(Figure 20-21).  The western blot showed protein was obtained in the Sf9 media 
and pellet.  More protein was found in the cell pellet, however multiple bands 
were present.   Further characterization studies were performed with the Sf9 















Figure 20:  SDS-PAGE of purified NPP6 expressed in Sf9 cells.  
Samples 1-4 were the various collection fragments from the column.  
Sample 1 was the first 5ml collected from the column that obtained pure 





2.1.4. BASIC TECHNIQUES 
  2.1.4.1. SITE-DIRECTED MUTAGENESIS 
Site-Directed Mutagenesis is a valuable technique in the study of protein 
structure-function relationships.  It uses a polymerase chain reaction (PCR) that 
deletes or inserts point/multiple mutations in a known DNA sequence.  PCR is a 
technique to amplify copies of DNA.  The polymerase replicates both plasmid 
strands of the DNA template.  Two oligonucleotide primers (to anneal to the 
sense strand and the antisense strand) containing the desired mutation were 
constructed using the QuikChange Primer Design Program [Stratagene] and the 
primer design guidelines [Stratagene].  During thermocycling the primers 
annealed to the DNA and were extended to produce the mutated plasmid with 
staggered nicks.  After thermocycling, the plasmid was treated with Dpn I 
endonuclease (target sequence:  5’-Gm6ATC-3’) which specifically digests 
 
 
Figure 21:  Western blot showing expression of NPP6ex in Sf9 cells.  
Pellet and soluble fractions are shown. 
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methylated and hemimethylated parental DNA.  Transformed XL-Blue 
supercompetent cells repaired the nicks on the daughter double stranded DNA 














2.1.4.2. CELL CULTURE 
 Bacteria 
Competent cells were transformed with the NPP6ex-containing plasmid for 
protein expression and cultured in 100ml LB medium with the appropriate 
antibiotic at 37ºC.  Protein expression was induced by the addition of IPTG to a 
final concentration of 1mM when the optical density at 600nm (OD600) of the 




Figure 22:  Site-directed mutagenesis protocol.   
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in the exponential growth stage.  Cells double every 30 minutes in the 
exponential phase provided the proper nutrients.  IPTG binds to the lac repressor 
of the lac operon and triggers protein production.   
 Mammalian 
Human embryonic kidney (HEK293) cells were grown to 85% confluence 
and plated into 150cm2 cell culture flasks.  DNA was transfected into the adhered 
HEK293 cells using the PolyFect Transfection Reagent.  The PolyFect Reagent 
assembles DNA into liposomes, which facilitate DNA entry into the mammalian 
cells [30-31].   
Insect 
Transfections were performed in 6-well plates using 9x105 Sf9 cells/well in 
2ml of Sf900IIISFM supplemented with 50ug/ml streptomycin and 50 U/ml 
penicillin.  The cells attached to the plates after 1 hour of incubation at 27ºC.  
High titer viral stocks were obtained after 5-7 days of infection.  The recombinant 
protein was expressed in Sf9 insect cells.   
2.1.4.3. ELECTROPHORETIC TECHNIQUES 
2.1.4.3.1. DNA GEL ELECTROPHORESIS 
DNA gel electrophoresis is a technique to separate DNA fragments by 
size.  DNA carries a net negative charge due to its phosphate backbone.  When 
the DNA is in an electric field, the negatively charged DNA will migrate through 
the gel toward the positive anode.  Different sized fragments of DNA migrate 
according to size.  Longer DNA fragments migrate slower; whereas shorter DNA 
fragments migrate faster.  Separated DNA fragments are analyzed by UV light.  
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Once cells were grown according to section 2.1.4.2, and DNA was purified 
by miniprep, the DNA samples were added to a 2% agarose horizontal gel.  The 
gel was composed of agarose powder made in Tris base, acetic acid, and EDTA 
(TAE) buffer.  Samples were combined with equal amounts of loading buffer 
(bromocresol green) as a visual marker to ensure the DNA did not run off the gel.  
The DNA samples were pipetted in 15 l aliquots into each well.  The gel was run 
for 45 minutes at 75V, stained in ethidium bromide (EtBr) for 15 minutes, and 
destained with distilled water for 15 minutes.  EtBr is an intercalating agent used 
as a fluorescent marker.  When exposed to UV light EtBr fluoresces, indicating 
the presence of DNA.  
   2.1.4.3.2. SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
is a technique used to separate protein fragments according to size and charge.  
When negatively charged proteins come in contact with SDS buffer, two 
molecules of SDS bind in proportion to their molecular mass.  The negatively 
charged protein:SDS complexes migrate toward the positively charged electrode.  
Smaller mass fragments migrate faster whereas larger mass fragments migrate 
slower.  Separation of protein fragments is analyzed by Coomassie stain. 
Once the bacteria were grown according to section 2.1.4.2., bacterial cells 
were harvested 4 hours after induction by centrifugation at 6000 x g for 10 
minutes at 4ºC.  Resuspended samples of 30ul were lysed and centrifuged to 
separate the pellet (P) from the cell lysate (C.L).  Whole cell (W.C.) samples of 
15ul were collected directly from the culture.  Equal volumes of SDS buffer were 
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added to each sample, boiled for 10 minutes, and centrifuged at 10,000 x g for 2 
minutes at 37ºC.  The protein samples were pipetted in 12 l aliquots into each 
well into a 4-15% gradient Tris-HCl-SDS-PAGE.  The gel was run for 1 hour at 
100V, stained with coomassie stain for 30 minutes, and destained with distilled 
water for 2-4 hours.  A white light illuminator was used to visualize the protein 
bands. 
2.1.4.4. CHROMATOGRAPHY 
   2.1.4.4.1. NICKEL COLUMN CHROMATOGRAPHY 
Nickel column chromatography is a protein purification technique.  
Modifying a protein to carry a histidine-tag (His-tag) gives the protein a binding 
affinity to nickel ions that other proteins in a mixture typically would not have.  
When the nickel ions are immobilized on a column, the His-tagged protein binds 
to the nickel ions allowing all other proteins to pass through, leaving the His-
tagged protein bound.  Once increasing concentrations of imidazole compete for 
the nickel binding sites, the His-tagged protein is released.      
2.1.4.4.2. FAST PROTEIN LIQUID 
CHROMATOGRPHAY 
Fast protein liquid chromatography (FPLC) is a technique used to 
separate and purify proteins from a mixture of proteins.  FPLC utilizes a column 
to separate proteins, such as the nickel column described in section 2.1.4.4.1.  
When a nickel column is set up in a FPLC, proteins are separated according to 
an affinity tag.   
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Purification of NPP6ex was scaled up by growing large bacterial cultures 
(1L) of cells induced with 1mM IPTG as described in 1.4.2.  The clarified lysate 
was loaded onto a 1ml nickel agarose affinity gel column by a Gilson Minipulse 3 
peristaltic pump at 5mls per minute.  After the sample was loaded onto the 
column, the column was placed into the FPLC and set up to run at a rate of 1ml 
per minute.  The program used 100% buffer A for 10 minutes, and transitioned 
over 30 minutes to 100% buffer B for 10 minutes, and returned to buffer A for 10 
minutes.  Buffer A consisted of 50mM sodium phosphate, 0.3M sodium chloride, 
and 10mM imidazole.  Buffer B consisted of 50mM sodium phosphate, 0.3M 
sodium chloride, and 0.5M imidazole.   
2.1.4.4.3. ANTI-FLAG GEL COLUMN 
CHROMATOGRAPHY 
Anti-FLAG gel affinity column chromatography is a technique used to 
separate a Flag-tagged protein from a mixture of proteins [32-33].  The FLAG-
tagged protein binds to the anti-FLAG column, allowing other proteins to pass 
through, leaving the FLAG-tagged protein bound.  The FLAG-tagged protein 
elutes under acidic conditions.      
NPP6ex was generated by passing the media over an ANTI-FLAG M2 Gel 
affinity column [Sigma-Aldrich] equilibrated in Tris-buffered saline (TBS) prepared 
according to the manufacturer’s instructions [Sigma] (50mM Tris, 150mM NaCl, 
pH 7.4).  Protein bound to the column was washed with 20 column volumes of 
TBS and eluted with 50ug/ml FLAG peptide, concentrated, and buffer exchanged 
into 10mM Tris, 10mM NaCl, pH 7.4. 
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2.1.4.5. CONCENTRATING PROTEINS  
 To concentrate the proteins an amicon ultra centrifugal filter with 10K 
molecular weight cut off (MWCO) filter was used.  The samples were centrifuged 
for 20 minutes at 4,000xg, with a starting volume of 15ml to yield approximately 
0.5ml.  Proteins were buffered exchanged into a 10mM Tris-HCl and 10mM NaCl 
buffer. 
  2.1.4.6. WESTERN BLOT 
 Western blot is a technique to detect proteins.  The procedure uses the 
SDS-PAGE technique described in section 2.1.4.3.2.  Bands were transferred 
onto a membrane and detected using antibodies specific to the target protein.   
Purified NPP6ex was separated by Tris-HCl-SDS-PAGE described in 
section 2.1.4.3.2 and transferred onto a polyvinylidene difluoride (PVDF) 
membrane (Bio-Rad) by electroblotting at 100V in Tris/Glycine/SDS buffer for 45 
minutes at 150V.  Membrane was incubated overnight with non-fat dry milk to 
prevent nonspecific antibody binding.  The membrane was then treated with 
ANTI-FLAG M2 antibody (Sigma) (1:2000 in TBST + 3% NFDM) and ANTI-goat 
peroxidase-labeled secondary antibody (Sigma) (1:5000 in TBST + 3% NFDM).  
The PVDF membrane was washed with TBS and stained with a 
chemiluminescent dye for detection by the FOTO/Analyst® Luminary System.  
Images of varying exposure times of 30 seconds, 1, 3, and 5 minutes were taken. 
2.2. FUNCTIONAL CHARACTERIZATION 
 2.2.1. OVERVIEW OF BIOASSAYS 
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Bioassays are a type of experimental test that measures the effect of an 
enzyme on a substrate.  When a hydrolysable substrate enters into the binding 
pocket of an enzyme a reaction occurs that produces a product.  Here, we 
measured the product based on either absorbtion of light or fluorescence 
emission upon excitation as a function of time.  The output is measured in 
absorbance or fluorescence units depending on the type of assay.  The amount 
of product produced is directly correlated to the catalytic activity of the enzyme.  
A catalytically active enzyme is one that produces a positive measurement.  
Here, we tested the catalytic activity of NPP6ex in the presence of possible 
feedback inhibitors using enzyme obtained from the mammalian expression 
system.     
  2.2.2. INHIBITION ASSAYS 
 Feedback inhibition occurs when a protein cleaves a substrate to yield a 
product that inhibits the enzyme, reducing the rate of product formation as 
product concentration rises.  NPP2, the second member of the NPP family, 
exhibits feedback inhibition by LPA 18:1 [34].  NPP2 hydrolyzes LPC to produce 
LPA and choline, and in turn, LPA inhibits further hydrolysis of LPC.  On the 
other hand, NPP6 hydrolyzes LPC to produce MAG and PC.  Currently, it is 
unknown whether MAG and PC are feedback inhibitors.  Both MAG and PC were 
analyzed for feedback inhibition.  Although not a product of NPP6, LPA was also 
tested to determine if it might serve as an endogenous inhibitor of NPP6. 
Previous literature reports that LPC 12:0 is one of the best substrates for 
NPP6 [4].  Therefore, MAG 12:0 was used for the inhibition experiments.  Both 
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MAG 12:0 and PC were tested for NPP6 inhibition using a concentration range of 
100 µM-10 mM.  Values at even the highest concentrations tested were in the 
same range as vehicle (no candidate inhibitor) as shown in Figure 23.  All assays 
were run using NPP6ex-containing (25nM) concentrated conditioned media 
(CCM) that was added in equal volume with 10 uM pNPPC and varying 
candidate inhibitor concentrations onto a 96 well plate performed in triplicate.  
Studies were performed over a period of two hours at 37°C at pH 8.  Absorbance 
at 405 nm as a function of time was detected; blanks and zero point values were 





































Figure 23.  Inhibition assays.  MAG 12:0, PC, and LPA 18:1 at 100 M 
concentrations were tested with 10 M of pNPPC.  
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As previously mentioned, LPA 18:1 is a feedback inhibitor of NPP2–
catalyzed hydrolysis of LPC [34].  Since NPP6 acts on LPC as well, LPA 18:1 
was tested as a potential endogenous inhibitor of NPP6 at a single, 100 µM 
concentration.  LPA was determined not to be an NPP6 inhibitor as shown in 
Figure 23 as no reduction in absorbance was observed relative to the vehicle 
control treatment.   
2.2.3. SUBSTRATES 
 The current literature describes several phosphodiester substrates for 
NPP6 [4] , but does not report all kinetic parameters for these known substrates. 
Experiments were designed to determine those values as well as to test whether 
substrates described for other NPP family members might also serve as 
substrates of NPP6.  Substrates were tested with three different assays; FS-3 
[23], Amplex Red, and para-nitrophenolate [4].  The assay for each substrate 
was selected based on the product of hydrolysis.  Explanation of the chemistry 
involved in the different types of assays can be found in sections 2.4.1., 2.4.2., 
and 2.4.3., respectively. 
FS-3 Assay:  FS-3  
 FS-3 [Echelon Biosciences Inc., Salt Lake City, UT] is a good substrate for 
NPP2 [35], but has not been tested as a substrate for NPP6. As NPP2 and NPP6 
show some cross-reactivity; an FS-3 bioassay (section 2.4.1.) was performed to 
determine if NPP6 can hydrolyze FS-3.  FS-3 is a very expensive compound 
therefore a single concentration of 33 M FS-3 was selected to test the catalytic 
activity of NPP6 against this substrate.  Fluorescence did not increase during the 
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time course of the assay indicating that the substrate was not hydrolyzed by 
NPP6. Thus, FS-3 was determined to be a poor substrate for NPP6 (Table 4). 
 
Amplex Red Assay:  LPC, GPC, and pNPPC  
LPC and GPC are natural substrates of NPP6, whereas pNPPC is a 
synthetic substrate of NPP6 [4].  NPP6 cleaves all three of these substrates to 
produce PC.  The Amplex Red assay (explained in section 2.4.2.) was used to 
couple the production of PC to resorufin, a product that can be detected using 
fluorescence.  LPC 16:0 was previously determined to be the best natural 
substrate of NPP6 therefore we used LPC 16:0 in all further studies mentioned 
[4].  Varying concentrations of LPC 16:0 (45-600 M [Avanti Polar Lipids]), GPC 
(6-750 M, synthesized in house by Louis Montedonico), and pNPPC (2-20 M 
[Sigma]) were used with equal volumes of concentrated conditioned medium and 
Amplex Red cocktail in a 96 well plate.  LPC 16:0, GPC, and pNPPC exhibited 
kcat/Km values of 1.8x10
7 M-1sec-1, 1.4x107 M-1sec-1, and 1.7x107 M-1sec-1, 
respectively (Table 4).  LPC 16:0, GPC, and pNPPC are similar substrates for 
NPP6.   
p-nitrophenolate Assay:  pNPPC and pNP-TMP 
The p-nitrophenolate assay is a simple assay requiring fewer steps than 
the Amplex Red assay.  As previously mentioned, pNPPC can be assayed using 
the Amplex Red assay.  It can also be assayed using the p-nitrophenolate assay 
[explained in section 2.4.3.].  NPP6 hydrolyzes pNPPC and pNP-TMP to produce 
p-nitrophenolate which has an absorbance maximum at 405 nm [4].  Varying 
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concentrations of pNPPC (2-250 M) and pNP-TMP (100-20000 M) were used to 
obtain kinetic parameters.  pNPPC and pNP-TMP exhibited kcat/Km values of 
1.8x106 M-1sec-1 and 5.2x102 M-1sec-1 (Table 4), respectively.  pNPPC was 
discovered to be the better synthetic substrate of NPP6 compared to pNP-TMP 
with a 3000 fold higher kcat/Km value.  The order of magnitude difference for 
pNPPC depending on the assay used to detect product could be due to the 
additives other than substrates used in the reaction.  The para-nitrophenolate 
assay is relatively quick.  The enzyme has one substrate to hydrolyze.  On the 
other hand, the Amplex Red assay has multiple enzymes, each with a substrate 
produced by the preceding reaction in the cascade.  Since the linear portion of 
the curve is taken for Vmax values, and there is a lag time in the Amplex Red 
assay, the difference in kcat/Km could be due to this. 
 
Table 4.  Kinetic parameters for NPP6-mediated hydrolysis of LPC 16:0, 
GPC, FS-3, pNPPC, and pNP-TMP  
 




 mean std 
dev 
mean std dev mean std dev   mean Propagated 
Error 
LPC 1.2x102 34 1.7x101 2.9 2.0x103 3.5x102 1.8x107 5.5x106 
GPC 5.1x101 11 5.6 0.1 6.7x102 1.4x101 1.4x107 2.7x106 
pNPPCa 2.9 0.6 4.3x10-2 9.1x10-4 5.1 0.1 1.8x106 3.5x105 
pNPPCb 7.6 0.4 1.8x10-2 1.8x10-2 1.3x102 2.1 1.7x107 9.9x105 
pNP-
TMP 
1.3x103 90 5.4x10-3 1.9x10-4 6.5x10-1 2.3x10-2 5.2x102 4.0x101 
a Kinetic parameters for pNPPC were determined using the p-nitrophenolate 
assay. 




2.2.4. METAL REMOVAL BY EDTA 
 NPPs contain two endogenous divalent metal cations within the catalytic 
binding pocket.  It is unknown whether the divalent metal cations play a structural 
or solely functional role.  Sakagami and colleagues previously reported that 
ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid 
(EGTA) treatment eliminated NPP6 function [4].  Therefore, in our studies we 
used EDTA to remove the divalent metals to determine if the divalent metals 
influence NPP2, 6 and 7 structure as well as function. 
The p-nitrophenolate assay with pNPPC was used to test the catalytic 
activity of NPP6 and 7 as a function of EDTA concentration whereas FS-3 was 
used for NPP2.  First, 2 l of 6 M protein was incubated with 2 l of varying 
concentrations of EDTA for 30 minutes or 16 hours at 4°C at pH 8.  The 
EDTA:NPP molar ratios were 0, 1, 2, 4, 8, 20, and 120.  Experimental results 
(Figure 24) showed that an incubation period of 16 hours was sufficient to 
eliminate activity at the highest molar excess of EDTA (120-fold higher than NPP 
concentration).  This effect was dose-dependent as the 20-fold molar excess of 
EDTA over NPP2, 6, and 7 but not lower EDTA excesses resulted in reduced 
catalytic function.  The more limited 30-minute incubation had a substantially 
smaller impact on enzyme function.  These data confirm the finding of Sakegami, 



























Figure 24.  Metal removal impact on substrate hydrolysis by NPPs.  A.  
Effect of EDTA treatment on hydrolysis activity of NPP6 and 7 toward 
pNPPC expressed as percent response relative to untreated NPP6 and FS-
3 toward NPP2.  Open bars indicate effect of 30 minute EDTA treatment.  




























Figure 25.  Metal restoration impact on substrate hydrolysis by NPPs. 
Effect of metal restoration on hydrolysis of pNPPC on NPP6 and NPP7 and 
FS-3 on NPP2.  Open bars indicate effect of 30 minute metal treatment.  




2.2.5. METAL RESTORATION 
 After metal removal by EDTA treatment, Sakagami and colleagues 
reported that attempts to rescue EDTA-treated NPP6 activity at a pH 8.5-9.5 
using the divalent metal cations Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Ni2+, and Zn2+ were 
unsuccessful [4].   Here, we tested the same seven divalent metal cations, in 
addition to Mn2+, to investigate metal restoration of NPP6 catalytic activity in 
addition to NPP2 and 7.  We repeated the metal restoration experiments 
because Sakagami and colleagues provided no details on how the group 
performed these experiments.  Absent details included metal concentrations, 
experimental set-up, temperature, and time frame.  
The ability of divalent metal ions to restore NPP2, 6, and 7 catalytic 
function was evaluated using NPP6 pre-treated for 16 hours with a 120-fold 
molar excess as described in section 2.2.4.  The EDTA:NPP solutions were 
diluted 100 fold with assay buffer (500mM NaCl, 100mM TRIS-HCl, and 0.05% 
Triton X-100).  Eight divalent metals were selected to determine if any of these 
metals could restore catalytic activity.  These divalent metals were selected 
based on their presence in biological systems in previously reported literature 
[36-43].  The metals included Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, and Zn2+.  
Aliquots (100 l) of EDTA:NPP dilutions were combined with 100 l of 3mM 
divalent metal ion solutions to give a 1:120:1X105 molar ratio of NPP:EDTA:Metal 
and incubated at either room temperature for 30 minutes or for 16 hours at 4°C at 
pH 8.0.  Activities of treated enzyme were measured using pNPPC for NPP6 and 
52 
 
7 or FS-3 for NPP2.  Assays were performed with 40 l of EDTA:NPP:metal 
complexes and 20 l of 30 M pNPPC for NPP6 and 7 (Figure 25).  
 Similar results were obtained after both 30 minutes and 16 hours.  
Comparison between treatment times demonstrates that any restoration of 
activity a particular metal could provide was complete within 30 minutes.  
Ultimately, it took the divalent metals less time to restore catalytic activity than it 
took for the endogenous divalent metals to be removed (higher kon than koff rate).  
Zn2+ restored catalytic activity for all three isoforms where Co2+ showed different 
results.  Co2+ was able to hyperactive NPP2, restore complete activity to NPP7 
and was unable to restore activity to NPP6.  Unlike that reported in previous 
literature [4], here we were able to demonstrate Ca2+ and Zn2+ restored almost 
complete activity for NPP6; whereas the other metals had little to no effect.  Ca2+ 
and Zn2+ may have restored activity for NPP6 due to the pH at which we 
performed our experiments.   
The Zn2+ restoration experiment did not appear to restore activity at pH 8 
and a white precipitate was observed.  Such a precipitate would interfere with the 
absorbance assay used to detect product.  Another assay was performed at pH 
7.5, catalytic activity was restored and no precipitate was observed.  Several 
species such as Zn(OH)2 or p-nitrophenolate salts can be considered as a 
potential source of the precipitate.  Zn(OH)2 and Cu(OH)2 both have very low Ksp 
values, 1.2x10-17 and 1.6x10-19, respectively [44].  Precipitation in the zinc-treated 
sample was observed at pH 8; however no precipitation was observed in the 
copper-treated sample in pH 8 buffer, although the overall solubility of Cu(OH)2 is 
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lower than that of Zn(OH)2.  Therefore, Zn(OH)2 is not the precipitate observed in 
the experiment.  Another candidate could be salt formed between the product p-
nitrophenolate and the metal ions [45].  The concentration of product increases 
over time, and the concentration of the anionic form of the product increases as 
the pH increases.  Ksp values for para-nitrophenolate salts of the metals tested 
are not available, but the delayed appearance of precipitate in this bioassay 
suggests that it was a para-nitrophenolate salt that precipitated once the para-
nitrophenolate concentration reached a high enough level.     
2.3. STRUCTURAL CHARACTERIZATION 
Proteins can be structurally characterized by circular dichroism (CD) 
experiments [46].  CD refers to the differential absorption of left and right 
circularly polarized light [46].  The chromophore giving rise to the spectra is due 
to the peptide bonds and amino acid sidechains with the greater sensitivity to 
secondary structure coming from the peptide bond.  The CD signal arises when 
the chromophore is located in a regular folded environment.  Ellipticity is the unit 
of circular dichroism and is measured as a function of wavelength.  The 
absorbance range 190-260 nm can be used in protein studies to characterize 
different secondary structural types such as alpha helix, beta sheet, and random 
coil.    Beta sheet content is reflected by a negative value at 215nm.  Alpha 
helical structures give rise to three distinct areas with a positive value at 190nm, 
and negative values at both 208nm and 222nm.  Random coils exhibit a negative 




  2.3.1. WAVELENGTH SCANS 
 To determine if the endogenous divalent metals play a structural role in 
NPP6, CD experiments were performed.  CD samples contained 1 M NPP in 
10mM Tris, 10mM NaCl, buffered to pH 7.4 in all cases except for Zn2+ and the 
untreated/EDTA-treated controls for Zn2+ which were performed at pH 7.0.  All 
Zn2+ experiments were performed at pH 7.0 due to precipitation at pH 7.4.  As 
described in sections 2.2.4., NPP6 treated with EDTA was incubated for 16 hours 
before addition of metal ions followed by an additional 30 minute incubation.  
Molar ratios of EDTA:NPP:metal were kept at 120:1:105 for NPP6 and 7 and 
2000:1:105 for NPP2.  Wavelength spectra were recorded from 190nm to 260nm 
using the AVIV model 410 spectrometer (Figure 26).  All measurements, except 
on Zn2+ and corresponding control samples, were performed at 25°C in a quartz 
optical cell with a path length of 1mm.  Wavelength spectra of Zn2+ sample sets 
were recorded in a 1cm cell due to precipitation of Zn(OH)2 in solution with pH ≥ 
7.0 at the higher protein and metal concentrations required for CD studies 
compared to functional studies.  All other metals examined by CD have a much 
higher Ksp value and did not exhibit precipitation.  Matched buffers were 
measured and the raw data were normalized by subtracting the baseline of the 
matched buffers.  The normalized data was converted to mean residue molar 
ellipticity ( mol) (Equation 5).  The cell path length (I) used was 1 cm.  net 
(normalized observed ellipticity), a.a. (number of amino acids within the protein), 
and c (concentration) were used to solve Equation 5.  mol was plotted as a 
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function of wavelength to obtain spectra.  The reported spectrum is an average of 





NPP6 treated with EDTA, NPP6 (untreated), and NPP6 treated with EDTA 
and metal ions all showed similar secondary structure content when examined by 
wavelength scans using CD over a wavelength range of 250-200 nm (Figure 26).  
The same results were seen in NPP2 and NPP7 tested under the same 
conditions.  The secondary structure content for NPP6 was estimated using 
DICHROWEB, an online deconvolution server for protein CD spectra [47-52] 
NPP6 (untreated) was found to have 33% - helical content, 18%  strand, and 
49% random coil.  When testing NPP6 after EDTA treatment, the secondary 
structure proportions changed only slightly (Table 5).  Subsequent addition of 
either calcium or zinc also produced little change in secondary structure 







mol = l * net / (a.a. * c)    (Equation 5) 
. 




























Figure 26.  Impact of metal removal and restoration on secondary 
structure of NPPs.  Effect of metal removal and restoration on 
secondary structure and stability of NPP2, 6, and 7.  Samples were 
incubated with or without EDTA at 4°C overnight, then with or without 
divalent metal cations for 30 minutes at room temperature. 



























Figure 27.  Impact of metal removal and restoration on stabilities of 
NPPs.  Effect of metal removal and restoration on of NPP6.  Samples were 
incubated with or without EDTA at 4°C overnight, then with or without 
divalent metal cations for 30 minutes at room temperature. Wavelength 











2.3.2 THERMAL DENATURATION 
 Thermal melts were performed to explore the thermal stability of NPPs 
and the ability of NPPs to refold after being heated to 100°C.  All protein 
complexes were monitored at 222nm as a function of temperature from 20°C to 
100°C.  All samples prepared for wavelength scans were diluted 10 fold with the 
same buffer in a 1cm cell for wavelength scans (except for Zn2+ as noted in 
section 2.3.1).  Raw data were collected at 2°C increments while samples were 
stirring.  An equation by Luthra and colleagues (Equation 6) was used to 
determine the folded fraction of each complex at any temperature [53].  [ ]obs 
(observed ellipticity), [ ]den (denatured ellipticity) and [ ]nat (natured ellipticity) are 
ellipticities at any temperature, highest temperature and lowest temperature, 






respectively. Protein stabilities were evaluated based on the temperature at 
which the folded fraction is 0.5 (T50). 
T50 is the temperature at which 50% of the protein is unfolded.  A protein 
with a high T50 value is more stable than one with a low T50.  Untreated NPP6 
had a T50 of 58°C (Figure 27).  NPP6 treated with EDTA (T50 = 65°C) had an 
increase in T50 value when compared to the untreated sample.  When 
EDTA:NPP6 was treated with either Ca2+ and Zn2+, a decreased T50 was 
observed (54°C) (Figure 27 and Table 6).  Similar results were seen when NPP2 
and 7 were tested under the same conditions.  Metal restoration after EDTA 
treatment caused the protein to unfold at a slightly lower temperature.  The 
protein is less stable with the addition of metals after the removal of its 
endogenous metals.  The Ca2+ and Zn2+-treated NPP6 samples unfolded at a 
lower temperature (-4°C) compared to the untreated sample (Table 6). 
After NPP6 was heated to 100°C in the previous experiment, the protein 
was cooled to 20°C to discover if the protein would refold.   The ellipticity did not 
increase to its original value when the temperature was lowered back to the 
starting point; therefore the protein remained unstructured (not shown).  An 
attempt to retest the activity of the unstructured protein was made, however the 
protein appeared to precipitate out of solution.  Therefore, the protein was no 












 2.4. GENERAL METHODS 
  2.4.1. FS-3 ASSAY 
 FS-3 is a fluorescence resonance energy transfer (FRET)-based 
phosphodiesterase substrate originally reported for assays of NPP2 catalytic 
function[35].  FRET relies on the distance-dependent transfer of energy from a 
donor group (carboxy-fluorescein) to an acceptor group (DABCYL:  4-
[dimethylamino]-4’-carboxyazobenzene).  When FS-3 is hydrolyzed by an 
enzyme it yields a fluorescent molecule and a quencher.  As the fluorescent 
molecule diffuses away from the quencher, the fluorescent molecule can be 
detected at excitation and emission wavelengths of 485 and 528 nm, 
respectively.  













NPP2 77 92 71 68 62 52 
NPP6 58 65 54 N/A N/A 54 




  2.4.2. AMPLEX RED ASSAY 
 Amplex Red is a sensitive method to measure lysophospholipase C/D 
activity [54].  Substrates that release choline or PC can be detected by this 
fluorescence assay.  Until now, radiometric assays have been used to monitor 
the radioactivity of substrates or products.  However, this procedure is tedious 
and costly.  On the other hand, the Amplex Red assay is a relatively easy 
method that avoids the use of radiolabelled samples.  Here, we explored the 
Amplex Red method to test the hydrolysis of various substrates with NPP6.  The 
original Amplex Red method [54] was first adapted to the NPP enzyme family to 
monitor the release of choline when LPC is hydrolyzed by NPP2.  However, 
when NPP6 cleaves LPC it produces PC [4].  In order to generate choline, 
alkaline phosphatase was added [54].  Choline was further oxidized by choline 
oxidase to betaine and hydrogen peroxide. Hydrogen peroxide in the presence of 
horseradish peroxidase reacted with Amplex Red to generate a fluorescent 
product, resorufin.  Resorufin has emission and excitation wavelengths of 530 







   
2.4.3. p-NITROPHENOLATE ASSAY 
 The p-nitrophenolate assay is a method to measure activity through the 
release of p-nitrophenolate as an enzymatic product [4].  When the enzyme 
hydrolyzes a substrate that produces p-nitrophenolate, absorbance at 405nm 
















Figure 28.  Amplex Red assay scheme. 
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2.4.4. CONTROL ASSAYS 
Resorufin 
 To obtain product concentrations from the Amplex Red assays, a standard 
resorufin calibration curve was required.  A range of resorufin concentrations (0-
10 M) was generated and fluorescence excited at 530nm and measured at an 
emission of 590nm as a function of time.  A linear regression line and equation 
were fit to a plot of fluorescence versus concentration.  The equation was used to 
convert observed fluorescence to product concentration. 
p-nitrophenolate 
 To obtain product concentrations from the p-nitrophenolate assays, a 
standard p-nitrophenolate control was run.  A concentration range (0.33-33 M) 
of p-nitrophenolate was generated and absorbance measured at 405nm as a 
function of time.  A linear regression line and equation were fit to a plot of 
absorbance versus concentration.  The equation was used to convert observed 
absorbance values to product concentrations. 
3.  MODELING AND MUTAGENESIS OF NPP6 
A homology model is a 3-dimensional (3D) model constructed of a target 
protein from its amino acid sequence using the 3D structure of a homologous 
protein as a template [55].  Homology models are created by selecting a template 
sequence that best matches the target sequence.  A good template should have 
a minimum 25% sequence identity with the target sequence [56].  The quality of 
the homology model is dependent on the alignment quality and accuracy of the 
assumption that homology in function and sequence indicates 3D homology.  
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Alignment quality is reduced when one or more amino acids are deleted or 
inserted into the sequence (Figure 30).  Once a homology model is generated, a 
Ramachandran plot can be used to visualize dihedral angles  and  of amino 
acids residues in a protein structure.  Homology models with very few  and  














3.1. MODEL DEVELOPMENT 
To build an NPP6 homology model, the amino acid sequence was 
acquired from the National Center for Biotechnology Information (NCBI) 
database.  The target amino acid sequence accession number is AY358676.  All 





GLRPDHHGIVHNSMRDPTLGG-FWLSKSEAVGDARWW-GGEPVWVGVENTGQHAATWSWPGSEAAIKGVRPSQWRHYQKG   
 
PTDINFANAVSDALDSFKSGRADLAAIYHERIDVEGHHYGPASPQRKDALKAVDTVLKYMTKWIQERGLQDRLNVIIFSD   
VRLDTRVDAVRGWLATDGAQRNRLVTLYFEHVDEAGHDHGPESRQYADAVRAVDAAIGRLLAGMQRDGTRARTNIIVVSD   
 
HGMTDIFWMDKVIELNKYISLNDLQQVKDRGPVVSLWPAPG-KHSEIYNKLSTVEHMTVYEKEAIPSRFYYKKGKFVSPL   
HGMAEVA-PGHAISVED-IAPPQIATAITDGQVIGFEPLPGQQAAAEASVLGAHDHYDCWRKAELPARWQYGSHPRIPSL   
 
TLVADEGWFITENREMLPFWMNSTGRREGWQRGWHGYDNELMDMRGIFLAFGPDFKSNFRAAPIRSVDVYNVMCNVVGIT   
VCQMHEGWDALFPDKLAK-------RAQRGTRGSHGYDPALPSMRAVFLAQGPDLAQGKTLPGFDNVDVYALMSRLLGIP  
 
PLPNNGSWSRVMCMLKGRAGTAPPVWPSHCALALILLFLLA   NPP6   




Figure 30. NPP6 protein sequence aligned with the bacterial XAC NPP 
protein sequence.  Black boxes represent sequence identity.   
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(MOE) software [Chemical Computing Group, Montreal Canada, version 
2009.10]. 
 An experimentally-characterized template structure was required to build 
the NPP6 homology model.  A good template is one that shares more than 25% 
sequence identity with the NPP6 amino acid sequence.  When searching the 
Research Collaboratory for Structural Bioinformatics Protein Data Base (RCSB-
PDB [57] the bacterial Xanthomonas axonopodis pv.citri (XAC) NPP amino acid 
sequence [58] was the most similar to the NPP6 amino acid sequence with a 
30.4% sequence identity.  For this reason, the bacterial XAC NPP crystal 
structure was selected as the best template to model the NPP family. 
The bacterial XAC NPP crystal structure was characterized by X-ray 
crystallography [20], a method to determine the arrangement of atoms within a 
crystal [59].  Basically, X-rays strike a crystal and diffract in different directions.  A 
3D structure of the density of electrons within the crystal can be determined from 
the angles and intensities of these diffracted beams.  In the RCSB-PDB [57], four 
X-ray crystal structures were determined by Zalatan and colleagues (entries 
2gso, 2gsu, 2gsn, and 2rh6) [58].  The difference among the four crystal 
structures is found within the binding pocket.  Entries 2rh6 and 2gsu were 
crystallized with adenosine monophosphate (AMP) and 2 zinc ions, 2gso was 
crystallized with vanadate and two zinc ions, and 2gsn was crystallized with two 
zinc ions.  
The crystal structure 2gsu was selected as a template for the NPP6 
homology model as it contained the product analog, AMP.  The product analog 
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provides information about interactions the phosphate group of substrates should 
make in the active site, even though NPP6 does not hydrolyze nucleotide 
substrates.  Once the template model was selected, 2gsu was aligned to the 
NPP6 amino acid sequence.  The template sequence had fewer amino acids 
than the target protein, therefore the N- (amino acids 1-21) and C- (amino acids 
375-398) termini of NPP6, which did not have corresponding residues in the 
template structure, were not modeled. 
A homology model was selected and docking studies were performed to 
predict residues likely to interact with incoming substrates.  However, new 
findings proved this model to be flawed due to improper tautomeric state of the 
histidine residues within the binding pocket before minimization.  Therefore, the 
model development was repeated with more careful attention to the tautomeric 
state of the metal coordinating histidine residues. A new homology model was 
selected from ten intermediate homology models and a final model that was 
generated.  To select the best NPP6 homology model, Ramachandran plots [60-
61] were generated for each of the eleven models.  Each model was examined 
for unusual or geometrically unreasonable features.  In addition,  and  angles 
were analyzed.  Since the homology model was generated to aid in the 
visualization of substrate binding to NPP6, the model with the fewest phi and psi 
angles outside of the highly populated regions of the Ramachandran plot 
(outliers) near the catalytic residue and divalent metal cations was selected.  
After carefully analyzing the eleven models, homology model number 11 was 
selected.  The homology model had eight phi and psi bond angle pairs noted as 
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outliers on a Ramachandran plot (Figure 31); however they were further than 
19Å away from the catalytic residue.  The outlier phi and psi bond angles were 
not expected to affect the outcome of subsequent modeling studies.  
Furthermore, the model was scrutinized to determine if the missing termini would 
produce errors during docking simulations.  Both termini are further than 17Å 
away from the catalytic site; therefore the missing residues extending from these 
positions were not predicted to participate in any catalytic activity, and their 
absence was expected to have little impact on subsequent modeling results. 
3.2. MODEL OPTIMIZATION 
Once a homology model was selected, the model was superposed on the 
template bacterial XAC NPP protein.  Six metal chelating residues occur in the 
catalytic binding pocket (D32, D193, H197, D240, H241, and H354) (Figure 32).  
The 3 metal chelating histidine residues were modeled in the tautomer that 
places a proton on the nitrogen oriented away from the two divalent metals.  The 



















Figure 31.  Ramachandran plots of selected NPP6 homology model.  Phi 




After the histidine residues were adjusted, the homology model was 
minimized using the AMBER99 forcefield [6] a forcefield suitable for proteins.  
Once again, the model was superposed on the bacterial XAC NPP crystal 
structure [58] to compare divalent metal ion positions and overall 3D structural 
similarity. 
  3.3. MODEL VALIDATION 
 Docking is a search for favorable binding configurations between ligands 
and a protein [62] .  Ligands can have many configurations called poses that are 
generated and scored to determine favorable binding modes.  The binding 
modes in our docking studies were constrained to a binding site.  Docking results 
are expected to be reliable when the ligands have limited flexibility and when the 
binding site is not particularly larger than the ligand [63].  MOE also handles 
ligands with 10 rotatable bonds reasonable well [63].   Systematic or stochastic 
 
 
Figure 32.  Catalytic site of NPP6.  A. AMBER [6] minimized homology model of 
NPP6 shown with protein (ribbon), metal chelating residues (stick) and divalent 
metal cations (space filling).  B. Close up view of the catalytic binding site with 
labeled metal chelating residues.  
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are examples of how conformational sampling can be performed.  A systematic 
search [64] is used to systematically rotate all non-ring bonds in fixed increments.  
Stochastic searches [64] randomly rotate all bonds, even in rings.  Here, the 
collections of poses are generated from sampled conformations using the alpha 
triangle placement method.  The alpha triangle placement method [65] takes 
poses generated by superposition of ligand atom triplets and triplets of the 
receptor site points, defined by alpha sphere centers.  Alpha sphere centers 
represent locations of tight packing against the protein.  A random conformation 
of the ligand is selected and a random triplet of ligand atoms is superposed on a 
random triplet of alpha sphere centers to produce a pose. 
   3.3.1. DOCKING STUDIES 
 Docking is a method that predicts the preferred orientation of one 
molecule when bound to another  [62, 66].   A model of the preferred orientation 
of substrate when bound to the enzyme can be used to generate experimentally 
testable hypotheses regarding the identity of residues predicted to interact with 
the substrate.   Subsequent comparative kinetic studies on wild type and mutated 
NPP6 proteins can be used to gauge the validity of the homology model. 
pNPPC and LPC 16:0 were docked in the binding pocket of NPP6 using 
two different docking types, completely and partially automated.  pNPPC is 
smaller in size, less flexible, and flexible docking is able to sample the degrees of 
freedom thoroughly.  LPC 16:0, on the other hand, is a larger substrate, and 
flexible docking did not adequately sample the conformational, positional, and 
orientational degrees of freedom.  pNPPC and LPC 16:0 were selected because 
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they represent the best synthetic and natural substrates for NPP6, respectively, 
based on previously recorded Km values [4]. 
The best known synthetic substrate, pNPPC, was flexibly docked into the 
NPP6 homology model.  The pNPPC structure was built, assigned charges, and 
minimized with the MMFF94x forcefield [67].  pNPPC was flexibly docked in the 
homology model near the catalytic residue, S71.  One hundred poses were 
retained and ranked according to energy.  All 100 poses were analyzed in the 
context of the superposed NPP6 homology model and the crystallized bacterial 
XAC NPP [20].  The best docked pNPPC pose was selected based on the 
superposition of the phosphate group of the docked substrate pose on the 
product, AMP, bound to the bacterial XAC NPP crystal structure.  When selecting 
the best docked pose two rules were followed:  the phosphate group in pNPPC 
needed to be in the vicinity of the phosphate group of AMP of the bacterial XAC 
NPP model and the leaving group of pNPPC was expected to be on the opposite 
side of the phosphate group from the catalytic S71 residue based on the 
proposed mechanism.   
LPC 16:0, the best natural substrate of NPP6, was built in MOE and 
minimized using the MMFF94x forcefield [67].  However, since LPC 16:0 is a 
hydrophobic and flexible substrate, docking studies did not position the substrate 
very well in the binding pocket.  Therefore, a smaller version of LPC (LPC 2:0) 
was built, minimized, and docked.  This segment of the molecule contains the 
polar atoms that are most likely to determine the preferred position due to their 
more directional and individually stronger interactions.  A conformational search 
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was performed to generate a database of 100 conformations of LPC 2:0.  The 
conformational database was then docked rigidly within the binding pocket to 
determine substrate position, and the best pose was selected based on the 
superposition of LPC 2:0 and AMP from the bacterial XAC NPP model following 
the guidelines applied to pNPPC.  After the best LPC 2:0 pose was selected, the 
remaining 14 carbons were added in two carbon units based on surface 
interactions with intervening minimization of the extended LPC with the NPP6 
atoms held fixed.   
Molecular dynamics (MD) is the study of the behavior of interacting 
molecules over time.  The simulation requires that the solvent, time interval, and 
total duration time be selected.  MD was used in these studies to examine the 
substrate interactions in the binding pocket over time while allowing flexibility in 
the protein sidechains, which were held fixed during docking.  Therefore, the total 
duration must be long enough to be relevant to the time scale of the natural 
process in picoseconds [68].  The time interval needs to be small enough to 
avoid discretization error (smaller than the fastest vibrational frequency in the 
system) [69].  The solvent relevant to the native environment of NPP6 is water; 
however we performed the simulations in the gas phase due to time and the 
explicit solvent calculations being computationally expensive.  Here, we used MD 































Figure 33.  Molecular dynamics simulations of NPP6 with LPC 16:0.  MD 
simulation of NPP6 homology model with LPC 16:0 docked into the binding 
pocket.  A and B. Overall placement of LPC 16:0 within the binding pocket at 
different times (132 ps and 167 ps, respectively).  Protein is represented by a 
blue ribbon.  Substrate is colored yellow (stick).  Displayed residues (ball and 
stick) were subjected to site-directed mutagenesis.  Color is dependent on 
experimental results.  Divalent metal cations are represented as teal spheres 
(space filling).  White represents insufficient dose response data to determine 
kcat/Km values (Y75A, Y157A, and W339A).  Gray represents WT behavior 
from mutant (R270A and W353A).  Red residues showed a decrease in 




Following docking studies, MD simulations were run on the fully-minimized 
(all atoms free to optimize) selected poses for both pNPPC and LPC 16:0 in the 
NPP6 model.  Simulations were initiated with a 50 ps heating phase during which 
the system temperature was increased from 10 to 300K.  The production phase 
of the simulations involved 1000ps of simulation time at 300K.  All data discussed 
come from the production phase.  For LPC 16:0, residues Y75 and Y157 showed 
hydrogen bond interactions to the carbonyl of the ester group on LPC at different 
times (Figures 33 - 35) which are consistent with the experimental data described 

















Figure 34.  Molecular dynamics simulations with LPC 16:0: Insight into 
residues Y75 and Y157.  MD simulation of NPP6 homology model with LPC 
16:0 docked into the binding pocket.  A and B. Hydrogen bond interactions (blue 
circle) with a surrounding residue selected for mutation.  Substrate is colored 
yellow (stick).  Displayed residues (ball and stick) were subjected to site-directed 
mutagenesis.  Color is dependent on experimental results.  Divalent metal 
cations are represented as teal spheres (space filling).  White represents 
insufficient dose response data to determine kcat/Km values (Y75A and Y157A).   
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distance less than 4Å from the LPC carbonyl oxygen to residue Y75.   On the 
other hand, Y157 has 52 sampled geometries less than 4Å and 2049 sampled 
geometries greater than 4Å (≤4Å = 2.5%).  Y75 clearly has a longer hydrogen 
bonding residence time with LPC 16:0 than does Y157 (Figure 35).  Y75 and 
Y157 both participate in supporting binding of LPC within the binding pocket due 
to close proximity (≤4Å) for hydrogen bond interactions (46.7% and 2.5%, 
respectively, of the sampled geometries ≤ 4Å).     
MD simulations for pNPPC showed that the residue Y157 was within 
hydrogen bonding interaction distance more frequently than Y75.  Y157 has 965 
sampled geometries less than 4Å and 1136 sampled geometries greater than 4Å 
(≤4Å = 45.9%, ≥4Å = 54.1%). The distance measured was from the nitro group 
on pNPPC to the hydroxyl group on the residue (either Y75 or Y157) (Figures 37 
- 38).  Only a small percentage of sampled geometries include hydrogen bond 
interactions with Y75 (≤4Å = 1.0%, ≥4Å = 99.0%) (Figures 37 - 38).  It is notable 
that the closest interaction observed for pNPPC with either Y75 or 157 (2.5 Å) is 
considerably longer than the closest interaction observed for these residues with 
LPC (2 Å), a finding consistent with the reduced impact of mutations at these 































Figure 35.  MD simulations of LPC.  MD simulations show hydrogen bond 
exchange in LPC 16:0 (boxed).  The distance between the hydroxyl group on 



























Figure 36.  MD simulations of pNPPC.   MD simulations show hydrogen 
bond exchange in pNPPC (boxed).  The distance between the hydroxyl group 




















Figure 37.  Molecular dynamics simulations of NPP6 with pNPPC.  MD 
simulation of NPP6 homology model with pNPPC docked into the binding 
pocket.   A. Overall placement of pNPPC within the binding pocket at 427ps.  
Pose showing transient hydrogen bonding interactions is shown.  B.  Close 
up view of possible H-bond interactions.  Residues shown (ball and stick) 
were selected for site-directed mutagenesis.  Color is dependent on 
experimental results.  Divalent metal cations are represented as teal spheres 
(space filling).  White represents insufficient dose response data to determine 
kcat/Km values (W339A).  Gray represents WT behavior from mutant.  Red 
mutated residues showed a decrease in activity (Y75, Y138A E143A, Y157A, 




 To determine which residues are important for substrate recognition by 
NPP6, substrate-residue interactions were analyzed in the initial flawed NPP6 
model.  Substrates such as pNPPC and LPC 16:0 were docked into the NPP6 
homology model and the best docked pose was selected.  Residues within close 
proximity (less than 4.5Å) to the substrates were visualized to determine if 
possible mutations could provide insight into understanding substrate recognition 
by NPP6.   Selection of residues to mutate by site-directed mutagenesis (found in 
section 2.1.4.1.) was based on possible - , cation- , and hydrogen bonding 





Figure 38.  Protein sequence of NPP6 with residues (boxed) selected for 
site-directed mutagenesis studies.   
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 Mutations were made in the mammalian expression system to validate 
predicted residues involved in substrate interactions.  Twelve mutation sites in 
total were selected after carefully analyzing substrate-residue interactions in the 
original NPP6 homology model.  VectorNTI software [Invitrogen, Carlsbad, CA, 
VectorNTI Advance™ 11] was used to design primers for Site-Directed 
Mutagenesis for each mutant (Table 3).  The following mutants were made; 
S71A, S71T, Y75A, Y138A, E143A, Y157A, E195A, H197A, R270A W339A, 
W353A, and H354A (Figure 38).  Mutants S71A, S71T, H197A and H354A were 
selected to show inactivity when the catalytic residue and metal chelating 
residues were mutated.  The remaining nine residues were selected for mutation 
based on pNPPC and LPC 16:0 interactions. 
 In the corrected homology model, the residues selected for mutation were 
colored according to the experimental data.  All experimental data was performed 
in triplicate.  A red residue represents an increase in kcat/Km value in the mutant 
compared to WT.  A residue is colored gray when the mutant acts like WT and is 
colored white when no kinetic data could be obtained for the mutant.  In each 
substrate complex with the homology model (Figures 33 and 37), the residues 
were colored according to the individual substrate interactions.     
W339A 
 Kinetic data could not be obtained for either pNPPC or LPC 16:0 with the 
W339A mutant (Tables 7 and 8).  W339 is located 12.5 and 13.5 Å from LPC and 
pNPPC, respectively, in the complexes obtained from docking.  These long 
distances suggest that the position of W339 could either be modeled incorrectly 
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or may have a role in maintaining the overall fold of NPP6 in its catalytically 
functional form.  To further look into the role of residue W339, we used MD 
simulations which showed that residues W339 and K257 with LPC 16:0 and 
pNPPC initially start (6.36Å and 5.94Å, respectively) with a cation-  type of 
interaction (Figure 39, panels A and B). Over the course of the simulations, 
W339 and K257 preserve the distance between each other (6.06Å) in LPC 16:0; 
however in the case with pNPPC the residues distance themselves further away 
from one another (13.75Å).  These residues sit on two different strands 
producing a parallel segment interaction.    As previously mentioned, W339 could 
possibly be modeled incorrectly as well.  We have very little confidence in the 
region where W339 is located in the model (Figure 39, panels A and B).  W339 
sits on a strand aligned against a sizable gap in the Xac. NPP template 
sequence (Figure 39, bottom panel).  A slightly different starting alignment in this 
region might include W339 in the alpha helical strand, which would change the 
position of W339.  The sidechain of W339 would be rotated relative to the 
structure shown in Figure 15A to sit in close proximity to the choline headgroup 
of the substrate.  This could provide an interaction with the choline headgroup, 
which would be consistent with the inactivity of this mutant against all substrates 
since all substrates tested had a choline headgroup.  We could test this 
hypothesis by using another substrate such as pNP-TMP, which lacks the 
choline headgroup and might therefore be hydrolyzed by the W339A mutant if 
W339 is modeled incorrectly, but would not by hydrolyzed by the W339A mutant 


















Y138A, E143A, and E195A 
The Y138A (4.5x104 M-1sec-1), E143A (4.7x104 M-1sec-1), and E195A 
(1.2x105 M-1sec-1) mutants showed decreased  kcat/Km when compared to WT 
(2.5x105 M-1sec-1) when tested with LPC 16:0 by 5.6-, 5.3- and 1.7-fold, 
respectively (Table 7).  The relatively small differences in kcat/Km are indicative 
that these residues do not make critical direct interactions with the substrate.  











Figure 39.  W339 and surrounding residues.  Panels A and B.  Protein (blue) 
shown with LPC 16:0 (yellow) within the binding pocket.  W339 is shown in ball 
and stick.  K257 is shown as in line.  Segment built from 2GSU template with 
poor confidence (red).  Panel B. is a closer view of the interactions between 
K257 and W339.  Bottom panel. An alignment of the amino sequence of NPP6 
target sequence and 2GSU template sequence.  Beta sheet content is 
represented by a red line. 
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position of LPC 16:0 in the homology model, consistent with the relatively small 
fold-differences in function of the mutants relative to the WT. 
The Y138A (1.3x106 M-1sec-1), E143A (2.4x106 M-1sec-1), and E195A 
(2.1x106 M-1sec-1) mutants also showed decreased  kcat/Km values when tested 
with pNPPC (Table 8) compared to WT (4.3x106 M-1sec-1), of 3.3-, 1.8-, and 2.0-
fold, respectively.  Again, the relatively small differences in kcat/Km are indicative 
that these residues do not make critical direct interactions with the substrate.  
Figure 37 shows that these residues are relatively distant from the docked 
position of pNPPC in the homology model, consistent with the relatively small 
fold-differences in function of the mutants relative to the WT. 
R270A and W353A 
The R270A (1.9x105 M-1sec-1) and W353A (1.5x105 M-1sec-1) mutants 
remained statistically unchanged in kcat/Km for LPC 16:0 when compared to WT 
(2.5x105 M-1sec-1) (Table 7).  Both R270 and W353 were distant from the choline 
headgroup of LPC 16:0 (>6.5Å and 12.5Å, respectively).  Therefore, no 
experimental changes in kcat/Km data were expected.   
The R270A (3.1x106 M-1sec-1) and W353A (1.3x106 M-1sec-1) mutants 
exhibited decreased kcat/Km for pNPPC compared to WT (4.3x10
6 M-1sec-1) 
(Table 8).  The fold decreases in kcat/Km were 1.4- and 3.3-fold, for R270A and 
W353A, respectively.  Although R270 and W353 exhibited decreases in kcat/Km, 
both were small fold changes compared to WT.  R270 is positioned 
approximately 5.5Å away from the choline group.  Mutation of R270 to an alanine 
had a very little decrease in kcat/Km this was due to the distance from R270 to the 
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choline group of the substrate.  The choline headgroup sits in good proximity 
5.5Å to W353 to form a cation-pi interaction.  When W353 was mutated to an 
alanine, a possible cation-pi interaction was lost between the pi system of W353 
and the cationic choline group of the substrate.  Mutating W353 to an alanine 
eliminated this interaction causing a reduced kcat/Km (1.3x10
6 M-1sec-1).  
Y75A and Y157A  
Mutating residues Y75 and Y157 to an alanine produced different 
experimental results when tested against LPC 16:0 and pNPPC.  The distinction 
was found in the fold-difference.  When testing Y75A and Y157A with LPC 16:0 
the mutants showed severe impairments in their ability to catalyze substrate 
hydrolysis.  kcat/Km values could not be obtained for either mutant (Table 7).  
Y75A and Y157A showed more modest decreases in kcat/Km value when tested 
with pNPPC (Table 8), of 1.8- and 1.7-fold, respectively.  An explanation for the 
loss in activity for LPC 16:0 is shown by MD simulations (Figures 33 and 35).  A 
hydrogen bond interaction between the hydroxyl groups of residues Y75 and 
Y157 and the carbonyl of the ester group of the substrate was discovered.  The 
hydrogen bonding distance at the closest approach of these residues with the 
carbonyl group is about 2.0 Å, a typical value for a hydrogen bond [70].  Although 
the majority of the simulation showed that a hydrogen bond involved Y75, for a 
very brief period of time, a hydrogen bond is created between the hydroxyl group 
of Y157 and the carbonyl of the ester group of LPC 16:0.  In LPC 16:0, 
dissociation of the hydrophobic tail in the absence of water altered the dynamics 
after 127 ps.  All measurements were taken from heavy atom to heavy atom.   In 
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contrast, when Y75A and Y157A were tested with pNPPC modest decreases in 
kcat/Km were found (Table 8), of (2.4 x10
6 M-1sec-1 and 2.5x106 M-1sec-1), 1.8- and 
1.7-fold, respectively.  During the majority of the simulation, the distance from the 
nitro group of pNPPC to the hydroxyl group of either Y75 or Y157 is greater than 
3Å, a relatively weak hydrogen bond.  The absence of the hydroxyl group on 
Y157 by mutating the residue to an alanine eliminates this weak interaction which 
modestly decreases the kcat/Km  (2.5x10
6 M-1sec-1) of the enzyme for pNPPC. 
To determine if the hydrogen bond interactions are pertinent to the 
substrate recognition by NPP6, further mutations of residues Y75 and Y157 to a 
phenylalanine will be performed in the future.  The mutations of Y75 and Y157 to 
phenylalanine will be tested to determine if the lost hydrogen bond interaction is 
the result of the inactivity of the NPP6:Y157A mutant.  Basically, the new mutant 
will eliminate the hydrogen bond and will demonstrate that sterics are not the 
primary difference. 
An additional set of experiments were performed to determine if hydrogen 
bonding to the carbonyl of the ester group of LPC 16:0 was responsible for this 
loss in activity of mutants Y75 and Y157 when tested with LPC; using lyso 
platelet activating factor (lysoPAF) 16:0, which lacked the carbonyl group (Table 
9).  Y75A activity was completely eliminated whereas the activity of Y157A was 
increased (1.3x108 M-1sec-1) 34-fold compared to WT (3.8x106 M-1sec-1).  The 
hydrogen bond interaction created by Y75 and the carbonyl group of LPC 16:0 
must be crucial for the catalytic activity of NPP6 (Table 9).  Y157A has an 
increase in activity for lysoPAF because Y157 does not interact by hydrogen 
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bonding.  LysoPAF is missing the carbonyl ester-linked oxygen which provides 
better access for the residue.  W353A was tested to determine if the choline 
head group of lysoPAF showed any differing results compared to WT.   
3.4. EXPERIMENTAL STUDIES 
 
 All experimental studies were performed using the Amplex Red assay 
(explained in detail in Chapter 2).  All mutants tested with LPC 16:0 were 
analyzed using 15 M-4mM substrate concentrations.  All mutants tested with 
pNPPC were analyzed using 2 M-20 M substrate concentrations. All mutants 









































Table 7.  Kinetic parameters for NPP6 mediated hydrolysis of LPC 16:0. 
 
 












WT 82 5.3 0.7 0.04 21 1.2 2.5x105 2.1x104 
Y138A 61 7.7 0.4 0.01 2.7 0.1 4.5x104 5.8x103 
W353A 120 12 1.1 0.5 17 7.6 1.5x105 6.5x104 
E143A 190 55 0.3 0.02 8.5 0.8 4.7x104 1.4x104 
E195A 66 13 0.4 0.2 7.2 3.3 1.2x105 5.4x104 
R270A 73 2.4 0.5 3.3x103 14 0.1 1.9x105 6.6x103 
 
 
Table 8.  Kinetic parameters for NPP6 mediated hydrolysis of pNPPC. 
 
 













WT 7.6 0.3 1.1 0.02 33 0.5 4.3x106 1.9x105 
Y138A 3.5 0.9 0.6 0.06 4.4 0.5 1.3x106 3.3x105 
W353A 38 11 3.1 0.5 47 7.9 1.3x106 4.0x105 
E143A 12 1.2 0.9 0.09 28 3.0 2.4x106 4.4x105 
Y75A 3.7 0.06 0.27 0.02 8.7 0.8 2.4x106 2.1x105 
Y157A 13 0.3 1.0 32 0.4 0.09 2.5x106 6.9x104 
E195A 4.1 1.1 0.5 0.04 8.1 0.8 2.1x106 5.6x105 
R270A 4.0 1.2 0.4 0.06 12 1.6 3.1x106 9.3x105 
 
 
Table 9.  Kinetic parameters for NPP6 mediated hydrolysis of LysoPAF. 
 
 













WT 4.3 0.6 0.5 0.05 16 1.5 3.8x106 6.0x105 
W353A 6.4 0.1 41 0.4 6.2x102 5.5 9.7x107 1.1x107 








4. CONCLUSIONS AND FUTURE DIRECTIONS 
 
Here, modified fusion protein containing the FLAG (DYKDDDDK) affinity 
tag at the C-terminus of NPP6-ex was expressed in insect cells and purified from 
the culture medium using anti-FLAG affinity chromatography or assayed without 
purification from mammalian cell culture medium.  In the insect cell expression 
system, substrate specificity was closely analyzed.  Substrates such as pNPPC, 
pNP-TMP, LPC, FS-3 and GPC were studied by bioassays and kinetic 
parameters were obtained for each.  kcat/Km values indicated that the natural 
substrate LPC 16:0 was the best substrate for NPP6 overall followed closely by 
the other natural substrate tested, GPC.  The best synthetic substrate was 
determined to be pNPPC.  pNP-TMP was determined to be the worst substrate 
overall for NPP6 out of the substrates tested with FS-3 showing no activity.  In 
the mammalian expression system, substrate recognizing residues were 
analyzed in the mammalian cells.  Here, experimental and computational 
methods were applied to characterize NPP6.  The crystallized bacterial Xac NPP 
shares 29.8% amino acid identity with NPP6, and therefore serves as an 
acceptable computational template for NPP6.  This model provided insight into 
substrate recognition, binding, and guided selection of mutation sites with which 
to validate the enzyme substrate model.  Experimental studies showed that Y75 
and Y157 are essential for LPC 16:0 hydrolysis however contribute modestly to 
pNPPC hydrolysis.  pNPPC lacks a hydroxyl group found on LPC 16:0.  This 
hydroxyl group may contribute to the noticeable source of difference in impact 
between substrates.  When Y75 and Y157 were both mutated to alanine no 
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kcat/Km values could be obtained for LPC 16:0.  This indicated that an interaction 
between the LPC 16:0 and the residues must be present.  Y75 and Y157 
hydrogen bond with LPC 16:0 at different times during an MD simulation of the 
modeled complex. To address if a hydrogen bond interaction occurs in situ 
phenylalanine mutants were designed.  In the near future these phenylalanine 
mutants will be tested to determine if a hydrogen bond interaction really occurs 
between LPC 16:0 and the residues.  No Kcat/Km values obtained when tested 
with Y75F or Y157F, residues lacking the hydroxyl group, would indicate that the 
hydroxyl group on the tyrosine residues is imperative in the participation of 
hydrogen bonding with LPC 16:0.  However, if positive Kcat/Km values are 
obtained this would indicate that the hydrogen bond interaction is not responsible 
for the difference among substrates and other possible interactions need to be 
explored.  Furthermore, the studies were carried out in the gas phase and the 
hydrophobic tail of LPC was shown to rotate outside of the binding pocket during 
the simulation.  Further MD simulations will be carried out by graduate student 
Erin Bonilla in the water phase.  These water phase simulations should promote 
retention of the LPC hydrophobic tail within the binding pocket due to its more 
favorable interactions with the protein than with water.  We expect in fully 
hydrated simulations that the hydrogen bond interactions between Y57 and Y157 
with LPC should alternate.  The catalytic binding pocket of the NPP family closely 
resembles the catalytic binding pocket of the APs which have six metal chelating 
residues coordinating two divalent metal cations.  Until now, the divalent metals 
were known to be required for function, but the correlation between their impact 
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on function and structure had not been investigated.   Here, we demonstrated 
that the functional role of the metals is unrelated to enzyme structure through 
bioassays and circular dichroism studies.  For all three isoforms tested, EDTA 
was able to access the endogenous divalent metals and eliminate catalytic 
function at 16 hours.  Incubation at 30 minutes was not sufficient to abolish 
activity.  The endogenous divalent metals were more slowly removed from the 
isoforms than they were restored based on catalytic function.  Various divalent 
metals were added to restore catalytic activity.  Ca2+ and Zn2+ (≤ 70%) almost 
completely restored activity.  Subsequently, when the metals were replaced 
catalytic activity was restored with Ca2+ and Zn2+ for NPP6.  Co2+, Ni2+, and Zn2+ 
restore activity for NPP7 whereas Co2+, Ni2+, Mn2+, and Zn2+ restore activity for 
NPP2.  The divalent metals were found to not play a role in the structure of 
NPPs.  Recently, Dr. Truc-Chi Pham investigated the identity of the metals using 
atomic absorption spectroscopy.  Zn2+ was discovered in a 2:1 ratio relative to 
protein for all three isoforms.  Similar results indication Zn2+ were the 
endogenous divalent metals among the three isoforms were published by Nureki 
and colleagues[71].  In addition, further studies were carried out with CD 
spectroscopy to determine secondary structure.  CD studies indicated that the 
endogenous divalent metals did not participate structurally toward NPP6.  No 
secondary structural difference was found among the enzyme, the EDTA treated 
enzyme, or the EDTA and metal treated enzyme.   In the future we can 
determine the structure and learn the tertiary structural impact of NPP6 by X-ray 
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B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C E V E I L G V R 
P T Y C L E Y K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
 
Appendix 1.1.  WT was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  B. 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L A Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C E V E I L G V R 
P T Y C L E Y K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.2.  S71A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L T Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C E V E I L G V R 
P T Y C L E Y K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.3.  S71T was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N A Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.4.  Y75A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y A W P G C E V E I L G V R 
P T Y C L E Y K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.5.  Y138A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C E V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.6.  E143A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C E V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.7.  E157A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V A G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.8.  E195A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G A H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.9.  H197A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H A Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.10.  H198A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D A 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.11.  R270A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G A H G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.12.  W353A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  
Bold and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 





























B. Protein Sequence 
 
M A V K L G T L L L A L A L G L A Q P A S A R R K L L V F L 
L D G F R S D Y I S D E A L E S L P G F K E I V S R G V K V 
D Y L T P D F P S L S Y P N Y Y T L M T G R H C E V H Q M I 
G N Y M W D P T T N K S F D I G V N K D S L M P L W W N G S 
E P L W V T L T K A K R K V Y M Y Y W P G C Y V E I L G V R 
P T Y C L E A K N V P T D I N F A N A V S D A L D S F K S G 
R A D L A A I Y H E R I D V E G H H Y G P A S P Q R K D A L 
K A V D T V L K Y M T K W I Q E R G L Q D R L N V I I F S D 
H G M T D I F W M D K V I E L N K Y I S L N D L Q Q V K D R 
G P V V S L W P A P G K H S E I Y N K L S T V E H M T V Y E 
K E A I P S R F Y Y K K G K F V S P L T L V A D E G W F I T 
E N R E M L P F W M N S T G R R E G W Q R G W A G Y D N E L 
M D M R G I F L A F G P D F K S N F R A A P I R S V D V Y N 
V M C N V V G I T P L P N N G S W S R V M C M L K G R A G D 
Y K D D D D K Stop 
 
Appendix 1.13.  H354A was cloned into pcDNA 3.1(+).  A.  Amino acid sequence.  Bold 
and underlined denotes mutated codon. B. Protein sequence.  Bold and underlined 
denotes mutated amino acid.  FLAG tag is denoted by an underline.  Stop codon is 
denoted as bold. 
